Ingrowing nail

L12_NAIL_INGROW

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L60.0 Hospital discharge: ICD-9 — 7030A Hospital discharge: ICD-8 — 70302 Cause of death: ICD-10 — L60.0 Cause of death: ICD-9 — 7030A Cause of death: ICD-8 — 70302 2 out of 7 registries used, show all original rules.	2508
4. Check minimum number of events None	2508
5. Include endpoints None	2508
6. Filter based on genotype QC (FinnGen only)	2231

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L60
Name in latin: Unguis incarnatus

NAME	L12_NAIL_INGROW
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L600
HD_ICD_9	7030A
HD_ICD_8	70302
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L600
COD_ICD_9	7030A
COD_ICD_8	70302
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Ingrowing nail based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17737	7233	10429
Only index persons	16406	6643	9763
Unadjusted period prevalence (%)
Whole population	0.26	0.21	0.29
Only index persons	0.32	0.24	0.37
Median age at first event (years)
Whole population	31.79	48.16	20.32
Only index persons	30.95	46.59	20.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2231	1195	1036
Unadjusted period prevalence (%)	0.45	0.42	0.48
Median age at first event (years)	42.91	50.12	34.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2324: Matched controls
23240

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

QDH00

NOMESCO Finland

Avulsion of toe nail

235.8

307.7

271

QDH01

NOMESCO Finland

Excision of nail bed in toe

902.5

307.7

379

L03.0

ICD-10 Finland

Cellulitis of finger and toe

7.6

307.7

673

1178

L60.0

ICD-10 Finland

Ingrowing nail

317.6

307.7

2037

508

QDH05

NOMESCO Finland

Correction of deformity of toe nail

98.7

285.1

148

7030A

ICD-9 Finland

Diseases of nail, Ingrowing nail

+∞

219.3

207

S94

ICPC

Ingrowing nail

12.2

185.1

191

170

J01FF01

ATC

clindamycin; systemic

3.0

135.1

889

3965

S22

ICPC

Nail symptom/complaint

4.5

119.8

328

825

70302

ICD-8 Finland

Diseases of nail, Unguis incarnatus

+∞

108.2

103

S09

ICPC

Infected finger/toe

5.7

93.3

181

338

J01DB01

ATC

cefalexin; oral

3.9

87.2

2107

16615

RJ410, ,

NOMESCO Finland

27.6

79.3

RJ411, ,

NOMESCO Finland

16.7

73.8

RJ421, ,

NOMESCO Finland

24.2

72.7

J01DA01

ATC

[U] cefalexin

2.2

68.8

1532

10861

J01CF05

ATC

flucloxacillin; systemic

3.4

67.9

272

879

RJ425, ,

NOMESCO Finland

122.0

66.2

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.3

65.7

181

452

L17

ICPC

Foot/toe symptom/complaint

2.2

64.9

846

4853

A10AB01

ATC

insulin (human); parenteral

4.5

62.8

160

376

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.7

61.5

118

217

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.9

61.1

189

513

RJ420, ,

NOMESCO Finland

17.6

61.1

D06AX01

ATC

fusidic acid; topical

2.9

61.0

314

1173

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

60.2

310

1158

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

59.7

667

3579

A10AB04

ATC

insulin lispro; parenteral

4.7

59.6

144

324

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.2

57.8

631

3348

L84

ICD-10 Finland

Corns and callosities

4.7

57.7

139

312

A10AC01

ATC

insulin (human); parenteral

3.2

56.9

250

852

A10AB05

ATC

insulin aspart; parenteral

3.1

56.2

258

902

C03CA01

ATC

furosemide; systemic

2.2

55.4

630

3390

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.0

54.5

160

418

N02AX02

ATC

tramadol; systemic, rectal

2.0

53.7

1034

6723

H04AA01

ATC

glucagon; nasal, parenteral

4.9

52.9

120

256

A10AE04

ATC

insulin glargine; parenteral

2.8

52.4

291

1128

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

11.3

51.2

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.3

49.6

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.4

49.6

128

303

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.2

47.5

129

318

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

47.4

326

1404

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.7

46.7

159

A11CC03

ATC

alfacalcidol; systemic

5.2

43.8

180

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.2

43.6

T89

ICPC

Diabetes insulin dependent

3.4

42.7

163

508

A10AA01, ,

ATC

4.3

42.3

111

266

SPAT1143

SPAT

Partial or complete excision of nail

9.8

42.2

N03AX16

ATC

[U] pregabalin

2.0

41.6

551

3094

L04AA06

ATC

mycophenolic acid; systemic

5.3

41.5

166

A10AA02, ,

ATC

4.0

41.3

119

306

A10AE05

ATC

insulin detemir; parenteral

3.1

41.3

181

613

H02AB04

ATC

methylprednisolone; systemic

2.3

41.2

365

1754

A46

ICD-10 Finland

Erysipelas

2.3

41.1

366

1762

R4180

NOMESCO Finland

Podiatric therapy

6.8

40.8

J01MA02

ATC

ciprofloxacin; systemic

1.8

40.7

873

5740

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

40.7

326

1500

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.3

40.3

159

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

40.1

291

1280

TQW80

NOMESCO Finland

Local dermatologic skincare

4.8

39.9

199

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

39.6

668

4064

R60.0

ICD-10 Finland

Localized oedema

2.4

39.2

315

1450

127

Kela drug reimbursment

Transplant complication

5.6

38.9

135

L60.8

ICD-10 Finland

Other nail disorders

7.1

38.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

38.6

520

2928

NHQ40

NOMESCO Finland

Amputation of toe

7.1

38.2

H3603, E103,

ICD-10 Finland

7.2

38.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

37.8

894

6019

L60.9

ICD-10 Finland

Nail disorder, unspecified

5.3

37.7

146

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

37.6

1055

7458

SPAT1262

SPAT

Handing over of treatment supplies

2.1

37.5

408

2122

Z94.0

ICD-10 Finland

Kidney transplant status

6.8

37.4

E0000UV, ,

ATC

1.8

37.4

1003

6999

S18

ICPC

Laceration/cut

1.7

36.8

1081

7729

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

13.1

36.6

L04AA01

ATC

[U] ciclosporin

6.7

35.8

RJ426, ,

NOMESCO Finland

+∞

35.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

35.1

185

694

RJ190, ,

NOMESCO Finland

42.7

34.1

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.8

33.8

161

L73.8

ICD-10 Finland

Other specified follicular disorders

10.1

33.6

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

9.4

33.6

N18.8

ICD-10 Finland

Other chronic renal failure

5.1

33.4

143

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.3

33.4

ZXA05

NOMESCO Finland

Left side

1.9

33.3

531

3147

J01DA09

ATC

[U] cefadroxil

1.8

33.3

621

3866

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

33.2

224

950

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

32.6

699

4530

A12AA04

ATC

calcium carbonate; oral

5.7

32.3

107

A02BC02

ATC

pantoprazole; systemic

1.7

32.1

1514

12124

L60.1

ICD-10 Finland

Onycholysis

6.7

32.0

M79.6

ICD-10 Finland

Pain in limb

1.7

31.9

1038

7534

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

31.8

144

496

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

31.8

508

3008

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

31.5

145

504

H02AB06

ATC

prednisolone; systemic

1.7

31.5

1055

7709

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

4.5

31.4

175

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.1

31.4

A10BA02

ATC

metformin; oral

1.8

31.3

601

3765

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.1

31.1

219

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

30.9

1001

7239

J02AC01

ATC

fluconazole; systemic

1.7

30.7

846

5859

M25.5

ICD-10 Finland

Pain in joint

1.7

30.7

805

5502

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.1

30.7

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

30.4

226

1001

J01MA12

ATC

levofloxacin; systemic

2.0

30.0

408

2285

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

29.6

150

550

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

29.3

212

927

S97

ICPC

Chronic ulcer skin

2.7

29.1

158

601

D01BA02

ATC

terbinafine; oral

1.8

29.1

587

3719

TQW99

NOMESCO Finland

Other minor procedure on skin

3.1

29.1

128

434

E66.8

ICD-10 Finland

Other obesity

2.7

29.1

168

660

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

29.0

542

3355

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

29.0

304

1549

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.0

28.7

127

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.2

28.4

271

1332

N03AX12

ATC

[U] gabapentin; oral

2.0

28.1

373

2068

N02BE01

ATC

paracetamol; systemic, rectal

2.0

27.9

2026

17933

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

27.7

282

1420

9759

FHL

Other measure in this category

146.8

27.7

Z3231

NOMESCO Finland

Registered nurse

1.7

27.6

617

4015

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

10.1

27.4

UJF32

NOMESCO Finland

Coloscopy

1.8

27.1

546

3446

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

27.1

510

3156

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

27.1

510

3158

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.1

26.6

112

N02AA05

ATC

oxycodone; systemic

1.9

26.5

376

2129

D01AE16

ATC

amorolfine; topical

2.1

26.5

262

1304

D07AC01

ATC

betamethasone; topical

1.6

26.4

803

5653

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

26.4

262

1306

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

26.4

113

377

L04AD01

ATC

ciclosporin; systemic

4.4

26.3

153

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

26.1

169

701

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

25.9

558

3583

Z71.8

ICD-10 Finland

Other specified counselling

1.6

25.9

822

5843

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.9

25.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

25.8

427

2538

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

25.8

1001

7468

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

25.7

313

1681

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

25.7

155

622

H3601, E103,

ICD-10 Finland

6.0

25.6

T90

ICPC

Diabetes non-insulin dependent

1.8

25.5

503

3149

205

Kela drug reimbursment

Chronic hypertension

1.8

25.3

471

2900

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

25.0

324

1777

J01FA10

ATC

azithromycin; systemic

1.6

25.0

1365

10993

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

24.9

161

667

RJ511, ,

NOMESCO Finland

32.4

24.6

M04AA01

ATC

allopurinol; systemic

2.1

24.6

252

1271

B01AB05

ATC

enoxaparin; parenteral

1.7

24.5

644

4352

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

24.5

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

24.4

604

4020

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

24.3

1197

9390

QDH00, ,

SPAT

8.9

24.2

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

24.2

524

3364

A10AD01

ATC

insulin (human); parenteral

4.4

24.0

143

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

23.9

1275

10167

ZXA00

NOMESCO Finland

Right side

1.7

23.9

539

3497

V03AE01

ATC

polystyrene sulfonate; oral

5.7

23.8

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

7.8

23.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

23.8

455

2818

SPAT1229

SPAT

Assessment of need for aid

2.4

23.8

165

707

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

23.8

261

1350

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

23.7

328

1838

9751

FHL

Nail removal in the operating room or under anesthesia

126.3

23.6

B35.1

ICD-10 Finland

Tinea unguium

2.3

23.5

186

845

D07AB08

ATC

desonide; topical

2.0

23.4

257

1329

TK800

NOMESCO Finland

Hemodialysis

4.0

23.3

168

A06AD11

ATC

lactulose; oral

2.0

23.2

293

1592

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.3

23.2

L70.0

ICD-10 Finland

Acne vulgaris

3.9

23.1

178

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.5

23.0

152

636

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.2

22.9

J01AA02

ATC

doxycycline; systemic

1.6

22.8

1666

14201

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.7

22.7

116

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.9

22.5

111

401

J01XC01

ATC

fusidic acid; systemic

4.9

22.5

101

R03AC02

ATC

salbutamol; inhalant

1.5

22.3

1245

9967

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

22.1

678

4741

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

22.0

153

656

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.3

21.9

252

J01FA06

ATC

roxithromycin; oral

1.6

21.9

835

6142

L04AX01

ATC

azathioprine; systemic

2.8

21.8

115

431

M03BX02

ATC

tizanidine; oral

1.5

21.7

1391

11441

L04AD02

ATC

tacrolimus; systemic

4.9

21.6

G47.3

ICD-10 Finland

Sleep apnoea

1.7

21.5

532

3522

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

21.5

415

2571

V03AE02

ATC

sevelamer; oral

8.3

21.4

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.4

21.4

R06AE07

ATC

cetirizine; oral

1.5

21.2

1002

7706

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

21.1

773

5624

137

Kela drug reimbursment

Uraemia requiring dialysis

5.8

21.0

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

20.9

515

3404

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.9

20.7

304

1732

M01AE02

ATC

naproxen; oral, rectal

1.5

20.6

1279

10395

A02BC05

ATC

esomeprazole; systemic

1.5

20.6

849

6329

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.6

20.6

188

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

20.6

227

1174

E000001, ,

ATC

1.7

20.5

445

2842

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

20.5

692

4932

ZX120

NOMESCO Finland

Intravenous

2.1

20.4

211

1065

N05BA04

ATC

oxazepam; oral

1.6

20.3

566

3855

R06.0

ICD-10 Finland

Dyspnoea

1.6

20.2

566

3858

M54.5

ICD-10 Finland

Low back pain

1.5

20.2

842

6287

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

20.2

655

4625

C07AB07

ATC

bisoprolol; oral

1.5

20.2

916

6965

Z49.2

ICD-10 Finland

Other dialysis

6.4

20.1

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

5.2

20.1

B05DB

ATC

Hypertonic solutions

6.6

20.0

QCH00

NOMESCO Finland

Avulsion of finger nail

58.0

19.9

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

19.8

459

2981

D07AC13

ATC

mometasone; topical

1.6

19.8

623

4363

R01AD08

ATC

fluticasone; nasal

1.6

19.8

641

4520

S29

ICPC

Skin symptom/complaint other

1.7

19.7

453

2935

D07AD01

ATC

clobetasol; topical

1.8

19.7

356

2159

WZC30

NOMESCO Finland

Teaching

1.8

19.7

360

2192

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

19.7

859

6469

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.5

19.7

C08CA01

ATC

amlodipine; oral

1.5

19.5

731

5322

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.9

19.5

319

ZXA10

NOMESCO Finland

Bilateral

1.7

19.4

376

2327

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

19.3

722

5253

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

19.2

1204

9747

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

19.2

326

1941

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

4.6

19.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

19.0

282

1612

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

18.8

256

1422

A10BJ06

ATC

semaglutide; parenteral

2.3

18.8

142

632

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

18.7

477

3169

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.7

18.7

102

389

P01AB01

ATC

metronidazole; oral, rectal

1.5

18.7

828

6237

Z3226

NOMESCO Finland

Physiotherapist

1.7

18.7

388

2445

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

7.1

18.7

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

18.6

320

1911

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.4

18.5

197

A02BC01

ATC

omeprazole; systemic

1.6

18.5

533

3650

S76

ICPC

Skin infection other

2.4

18.4

129

555

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

18.4

194

986

R51.80

ICD-10 Finland

Headache

1.7

18.3

379

2384

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

18.3

170

823

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

18.3

277

1592

SPAT1263

SPAT

Sampling

1.5

18.3

896

6884

B35.3

ICD-10 Finland

Tinea pedis

2.4

18.2

125

533

T82

ICPC

Obesity

2.5

18.2

115

472

RJ414, ,

NOMESCO Finland

21.9

18.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

18.2

468

3116

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

18.1

635

4543

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.3

18.1

205

H36.01

ICD-10 Finland

Diabetic maculopathy

4.3

18.1

108

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.5

18.1

160

Kela drug reimbursment

exenatide

3.6

18.1

171

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

18.0

216

1149

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

18.0

419

2719

J01CF02

ATC

cloxacillin; systemic

3.6

18.0

162

WX002

NOMESCO Finland

Sedation and analgesia

1.7

17.9

389

2478

B05DA

ATC

Isotonic solutions

5.9

17.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

17.9

215

1145

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

17.9

225

1218

A10BH01

ATC

sitagliptin; oral

2.0

17.8

194

999

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

17.7

159

A10BJ02

ATC

liraglutide; parenteral

3.0

17.7

276

N30.0

ICD-10 Finland

Acute cystitis

1.7

17.6

360

2257

L04AX03

ATC

methotrexate; systemic

1.9

17.6

222

1203

SPAT1310

SPAT

Counselling related to known health issue

1.5

17.5

668

4862

R50.9

ICD-10 Finland

Fever, unspecified

1.7

17.5

354

2212

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

17.4

1670

14581

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.5

17.3

171

L30.4

ICD-10 Finland

Erythema intertrigo

4.1

17.3

116

R52.9

ICD-10 Finland

Pain, unspecified

1.9

17.3

241

1348

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

17.2

815

6197

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.9

17.2

130

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.8

17.1

A10AE06

ATC

insulin degludec; parenteral

2.5

17.0

104

420

SPAT1301

SPAT

No procedures

1.5

17.0

635

4596

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

17.0

215

1166

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

16.9

150

713

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

16.9

539

3766

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.1

16.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

16.8

313

1909

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.7

16.8

363

XQ800

NOMESCO Finland

Prick test

2.1

16.8

175

885

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

16.8

225

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.6

16.8

100

399

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

16.7

216

1178

N06AX11

ATC

mirtazapine; oral

1.5

16.7

733

5483

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

16.5

559

3955

ZXD05

NOMESCO Finland

Urgent procedure

1.5

16.5

613

4426

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

16.5

292

1756

C10AA05

ATC

atorvastatin; oral

1.5

16.5

794

6047

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

16.5

155

755

L60

ICD-10 Finland

Nail disorders

5.7

16.3

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

16.3

315

1941

R4190

NOMESCO Finland

Nutritional therapy

2.4

16.3

113

484

CKC12

NOMESCO Finland

Photocoagulation of retina

2.5

16.3

100

405

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

16.2

580

4151

J01EA01

ATC

trimethoprim; systemic

1.6

16.2

489

3373

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.1

16.1

220

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

16.0

249

1442

N02BF02

ATC

pregabalin; oral

2.1

15.9

163

819

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.8

15.9

128

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

15.9

927

7309

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

15.9

1031

8293

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.9

15.7

L60.3

ICD-10 Finland

Nail dystrophy

13.0

15.7

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

15.6

259

1527

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

15.6

705

5289

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

15.5

209

1155

R07.3

ICD-10 Finland

Other chest pain

1.8

15.5

238

1371

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

15.5

305

1888

R11

ICD-10 Finland

Nausea and vomiting

1.9

15.5

208

1149

R42

ICD-10 Finland

Dizziness and giddiness

1.6

15.5

453

3097

SPAT1153

SPAT

Removal of sutures

1.5

15.4

599

4358

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

15.3

398

2645

L28

ICPC

Limited function/disability (L)

1.6

15.3

354

2287

N02BF01

ATC

gabapentin; oral

1.8

15.3

237

1370

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.0

15.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

15.2

1634

14353

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.9

15.2

J01FA09

ATC

clarithromycin; systemic

1.5

15.2

669

4988

N06AX21

ATC

duloxetine; oral

1.8

15.2

266

1594

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.6

15.1

359

N06AX16

ATC

venlafaxine; oral

1.7

15.1

330

2100

R01AD09

ATC

mometasone; nasal

1.4

15.0

997

8026

D07AA02

ATC

hydrocortisone; topical

1.7

14.9

317

2003

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.8

14.8

259

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

14.8

122

564

RJ210, ,

NOMESCO Finland

16.6

14.8

Z01.2

ICD-10 Finland

Dental examination

1.4

14.7

1060

8645

C09AA02

ATC

enalapril; systemic

1.6

14.7

335

2154

AA1AD

NOMESCO Finland

CT of head and brain

1.5

14.7

550

3964

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

14.7

222

1273

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.0

14.7

222

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

14.6

507

3594

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

14.6

219

1252

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

14.6

284

1751

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.0

14.6

104

D01AE15

ATC

terbinafine; topical

2.0

14.6

151

762

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

14.6

429

2933

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

14.5

144

715

N06AA09

ATC

amitriptyline; systemic

1.9

14.5

184

997

A10BJ05

ATC

dulaglutide; parenteral

3.2

14.4

187

L72.1

ICD-10 Finland

Trichilemmal cyst

2.2

14.4

117

537

A08

ICPC

Swelling

2.2

14.4

123

577

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

14.3

245

1457

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.3

347

2266

L85.89

ICD-10 Finland

Other specified epidermal thickening

17.1

14.3

R4110

NOMESCO Finland

Physiotherapy

1.5

14.2

569

4152

B07.9

ICD-10 Finland

Verruca simplex

2.4

14.2

419

M01AC06

ATC

meloxicam; systemic, rectal

1.5

14.2

705

5366

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

5.3

14.2

A10BK03

ATC

empagliflozin; oral

1.8

14.2

214

1226

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

14.1

1210

10143

R4120

NOMESCO Finland

Occupational therapy

2.0

14.1

150

765

L12

ICPC

Hand/finger symptom/complaint

1.6

14.1

403

2737

J01DA06

ATC

[U] cefuroxime

1.7

14.0

292

1833

R53

ICD-10 Finland

Malaise and fatigue

1.5

14.0

538

3892

SPAT1211

SPAT

Application of soft bandage

1.9

14.0

192

1068

L01BA01

ATC

methotrexate; systemic

2.6

13.9

308

G44.2

ICD-10 Finland

Tension-type headache

1.7

13.9

304

1933

RJ521, ,

NOMESCO Finland

30.2

13.9

A28

ICPC

Limited function/disability NOS

1.7

13.8

309

1976

RJ422, ,

NOMESCO Finland

53.7

13.8

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.2

13.7

177

L88

ICPC

Rheumatoid/seropositive arthritis

2.4

13.7

395

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

13.7

314

2021

A01

ICPC

Pain general/multiple sites

1.8

13.6

227

1339

SPAT1312

SPAT

General health counselling

1.4

13.6

661

5002

C02AC05

ATC

moxonidine; oral

2.4

13.6

397

ACC51

NOMESCO Finland

Release of median nerve

1.9

13.5

163

868

R03BA05

ATC

fluticasone; inhalant

1.6

13.4

384

2604

N05CF01

ATC

zopiclone; oral

1.5

13.4

615

4602

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

13.4

120

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

13.3

139

704

C10AA01

ATC

simvastatin; oral

1.4

13.3

681

5202

OAB50, ,

SPAT

1.9

13.3

175

961

A07AA02

ATC

nystatin; oral

2.2

13.3

114

536

SFA20

NOMESCO Finland

Two-surface restoration

1.4

13.2

1314

11236

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

13.1

142

729

C08CA13

ATC

lercanidipine; oral

1.7

13.1

267

1666

M48.0

ICD-10 Finland

Spinal stenosis

1.8

13.1

221

1309

M02AA07

ATC

piroxicam; topical

1.4

13.1

656

4989

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

13.1

145

751

XQ848

NOMESCO Finland

Dermatological photography

2.8

13.0

243

H01

ICPC

Ear pain/earache

1.7

13.0

281

1781

A10BB12

ATC

glimepiride; oral

2.2

13.0

111

521

J05AB01

ATC

aciclovir; systemic

1.5

13.0

449

3174

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

13.0

171

939

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.1

12.9

168

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

12.9

796

6277

H02AB07

ATC

prednisone; oral

1.7

12.9

257

1593

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.7

12.9

267

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

12.9

131

657

S80.0

ICD-10 Finland

Contusion of knee

1.8

12.9

183

1029

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

12.9

224

1338

A10BJ01

ATC

exenatide; parenteral

4.4

12.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

12.9

271

1705

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.5

12.8

321

E000006, ,

ATC

2.0

12.8

138

707

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

12.8

513

3735

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

12.8

201

ZXE00

NOMESCO Finland

One hour or less

1.4

12.8

770

6046

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

12.8

586

4380

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

12.8

240

1465

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.8

12.7

K02.1

ICD-10 Finland

Caries of dentine

1.4

12.7

1356

11695

SPAT1260

SPAT

Consultation of another employee

1.6

12.7

345

2310

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

9.7

12.7

WX892

NOMESCO Finland

Monitored bed care

1.9

12.7

154

823

C03DA01

ATC

spironolactone; oral

1.7

12.7

219

1306

D02AE01

ATC

carbamide; topical

2.0

12.6

136

697

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.3

12.6

100

455

B01AC04

ATC

clopidogrel; oral

1.7

12.5

272

1724

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

12.5

105

489

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

12.5

388

2677

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

12.5

443

3146

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

12.5

174

973

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

12.4

174

974

A02BC03

ATC

lansoprazole; oral

1.5

12.4

531

3913

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

12.4

452

WW200

NOMESCO Finland

Immunization

2.6

12.4

267

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

12.4

123

612

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.5

12.4

D07XC01

ATC

betamethasone; topical

1.7

12.2

231

1412

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

12.2

251

1569

A10BX04

ATC

[U] exenatide

4.3

12.2

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.1

12.2

115

561

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

12.1

148

792

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

12.5

12.1

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.2

12.1

154

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.9

12.1

K59.0

ICD-10 Finland

Constipation

2.1

12.1

115

563

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

12.1

678

5248

ZXC10

NOMESCO Finland

Use of laser

2.9

12.1

186

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

12.0

137

716

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

12.0

298

1954

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.5

11.9

120

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.9

11.9

187

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

11.9

300

1972

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

11.9

111

539

M01AH05

ATC

etoricoxib; oral

1.4

11.9

1324

11440

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

11.9

136

712

H3600, E103,

ICD-10 Finland

3.6

11.9

106

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.7

11.9

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

11.9

132

684

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

11.9

132

684

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

11.8

118

588

R52.2

ICD-10 Finland

Other chronic pain

2.3

11.8

403

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.9

11.8

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

11.8

316

A02BA02

ATC

ranitidine; systemic

1.6

11.8

333

2250

A07AA09

ATC

vancomycin; oral

3.6

11.7

107

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

11.7

1501

13248

B03XA01

ATC

erythropoietin; parenteral

4.9

11.7

WX290

NOMESCO Finland

Other blockage of nerve

1.4

11.7

1105

9300

QCH01

NOMESCO Finland

Excision of nail bed in finger

30.2

11.6

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

11.6

131

683

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

11.6

129

669

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

11.5

489

3591

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

11.5

129

670

C07AB02

ATC

metoprolol; systemic

1.6

11.5

325

2194

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

11.5

328

2220

NH3CG

NOMESCO Finland

Extensive MRI of foot

5.0

11.5

J20

ICD-10 Finland

Acute bronchitis

1.7

11.5

220

1350

C10AA07

ATC

rosuvastatin; oral

1.4

11.5

646

4996

N05AH04

ATC

quetiapine; oral

1.5

11.5

395

2784

R10.0

ICD-10 Finland

Acute abdomen

2.4

11.5

314

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.5

11.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

11.4

122

624

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

11.4

166

941

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

11.4

134

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

11.4

312

2092

RD210, ,

NOMESCO Finland

2.9

11.4

176

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

11.4

159

890

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.2

11.3

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

11.3

250

1591

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

11.9

11.3

Z96.4

ICD-10 Finland

Presence of endocrine implants

11.9

11.3

E000003, ,

ATC

2.2

11.3

443

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.6

11.3

244

XCK00

NOMESCO Finland

Perimetry

2.1

11.3

113

564

J01CA04

ATC

amoxicillin; systemic

1.4

11.3

1842

16870

N18.0

ICD-10 Finland

End-stage renal disease

4.3

11.2

H05BX01

ATC

cinacalcet; oral

5.6

11.2

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

12.8

11.1

N05BA01

ATC

diazepam; systemic, rectal

1.6

11.1

256

1646

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

11.1

146

801

L85.3

ICD-10 Finland

Xerosis cutis

3.9

11.1

Z00.0

ICD-10 Finland

General medical examination

1.5

11.0

403

2872

RJ412, ,

NOMESCO Finland

11.2

11.0

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

11.0

535

4025

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

11.0

163

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.1

11.0

142

E87.5

ICD-10 Finland

Hyperkalaemia

3.4

11.0

112

X58

ICD-10 Finland

Exposure to other specified factors

1.5

11.0

349

2417

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

11.0

302

-1, ,

NOMESCO Finland

1.4

11.0

739

5880

C10AX09

ATC

ezetimibe; oral

1.6

11.0

316

2142

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

10.9

377

2655

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

10.8

208

1276

WX320

NOMESCO Finland

Spinalanesthesy

1.5

10.7

458

3363

N30.2

ICD-10 Finland

Other chronic cystitis

4.6

10.7

NH3BG

NOMESCO Finland

MRI of foot

4.7

10.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

10.7

593

4564

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

10.7

427

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

10.7

386

2744

C08CA02

ATC

felodipine; oral

1.8

10.7

155

878

L04AB01

ATC

etanercept; parenteral

3.1

10.6

145

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

10.6

475

UKC02

NOMESCO Finland

Cystoscopy

1.6

10.6

255

1657

Z00.8

ICD-10 Finland

Other general examinations

1.8

10.6

177

1045

R06AX27

ATC

desloratadine; oral

1.4

10.6

634

4942

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

10.6

389

2775

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

10.6

167

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

10.5

247

1596

R05

ICD-10 Finland

Cough

1.5

10.5

436

3184

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.8

10.5

Z2221

NOMESCO Finland

Medical doctor

1.4

10.5

533

4041

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

10.4

617

4797

SPAT1216

SPAT

Assessment of functional ability

1.6

10.4

263

1728

J01FA01

ATC

erythromycin; systemic

1.6

10.4

285

1908

QDH10

NOMESCO Finland

Transfer of toe nail, microsurgical

+∞

10.4

K07

ICPC

Swollen ankles/oedema

2.2

10.4

425

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

10.4

153

870

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.0

10.4

147

R01AD58

ATC

fluticasone, combinations; nasal

1.4

10.3

552

4220

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

10.2

148

837

A04AA01

ATC

ondansetron; systemic, rectal

1.8

10.2

158

912

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

10.2

233

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

10.2

300

R03BA02

ATC

budesonide; inhalant

1.5

10.2

367

2607

B37.2

ICD-10 Finland

Candidiasis of skin and nail

4.1

10.2

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

10.1

117

615

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

10.1

146

825

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

5.3

10.1

C07AG02

ATC

carvedilol; oral

2.0

10.1

104

525

R5110, ,

SPAT

1.8

10.1

161

938

SPAT1254

SPAT

Administration of medicine

1.5

10.1

289

1955

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

10.1

444

M01AB01

ATC

indometacin; systemic, rectal

1.9

10.1

123

659

M77.4

ICD-10 Finland

Metatarsalgia

1.9

10.1

134

739

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

10.0

150

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.0

10.0

114

596

L57.0

ICD-10 Finland

Actinic keratosis

1.7

10.0

169

1000

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

10.0

242

1573

K03.66

ICD-10 Finland

Tooth plaque

1.7

10.0

179

1077

C05AA08

ATC

fluocortolone; rectal, topical

1.6

10.0

243

1582

R06AX22

ATC

ebastine; oral

1.5

10.0

351

2478

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.7

10.0

189

A10AD04

ATC

insulin lispro; parenteral

9.2

10.0

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

10.0

181

1093

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.0

363

2581

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

10.0

313

2160

L16

ICPC

Ankle symptom/complaint

1.6

10.0

265

1763

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.9

9.9

E66

ICD-10 Finland

Obesity

1.9

9.9

129

706

M01AX05

ATC

glucosamine; oral

1.5

9.9

312

2154

J01MA14

ATC

moxifloxacin; systemic

1.7

9.8

171

1021

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.6

9.8

J05AB11

ATC

valaciclovir; oral

1.5

9.8

286

1942

H02AB09

ATC

hydrocortisone; systemic

2.5

9.8

238

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

9.8

180

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

9.8

579

4496

L71.8

ICD-10 Finland

Other rosacea

4.7

9.8

9733

FHL

Excision of skin change in operating room or anesthesia

3.5

9.7

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

9.7

215

R13

ICD-10 Finland

Dysphagia

1.8

9.7

138

777

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.1

9.7

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

9.7

327

2291

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.6

865

7157

C03AA03

ATC

hydrochlorothiazide; oral

1.8

9.6

147

846

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

9.6

555

4291

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

9.6

446

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

9.6

747

6052

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

9.6

271

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

9.6

143

817

S06

ICPC

Rash localized

1.9

9.6

115

613

E000002, ,

ATC

1.6

9.6

226

1462

H03AA01

ATC

levothyroxine sodium; systemic

1.4

9.6

426

3148

D11

ICPC

Diarrhoea

1.5

9.6

268

1804

C09CA01

ATC

losartan; oral

1.4

9.5

452

3378

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

9.5

106

551

C09CA06

ATC

candesartan; oral

1.4

9.5

465

3495

SFA10

NOMESCO Finland

One-surface restoration

1.3

9.5

1218

10592

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

9.4

257

1718

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

9.4

256

1710

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

9.4

1518

13617

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

9.4

456

R06.4

ICD-10 Finland

Hyperventilation

3.1

9.4

129

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

9.4

172

1043

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.9

9.3

151

V03AE03

ATC

lanthanum carbonate; oral

8.1

9.3

L03

ICD-10 Finland

Cellulitis

3.8

9.3

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

9.3

217

1399

K07.60

ICD-10 Finland

Snapping jaw

1.9

9.3

111

591

C01DA14

ATC

isosorbide mononitrate; oral

1.6

9.3

212

1361

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.0

9.2

105

550

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

9.2

132

745

SPAT1252

SPAT

Overall medication plan or its review

1.9

9.2

115

622

T83

ICPC

Overweight

2.5

9.1

234

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.5

9.1

228

TK810

NOMESCO Finland

Hemofiltration

5.0

9.1

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.2

9.1

111

OAB74, ,

SPAT

3.4

9.0

XQ802

NOMESCO Finland

Epicutan test

2.1

9.0

382

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

9.0

317

M10.9

ICD-10 Finland

Gout, unspecified

1.9

9.0

117

641

XA402

NOMESCO Finland

ENMG

2.5

9.0

212

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

9.0

136

781

R05

ICPC

Cough

1.4

9.0

511

3936

H26.4

ICD-10 Finland

After-cataract

1.7

9.0

160

963

H3600, E113,

ICD-10 Finland

3.9

9.0

N03AE01

ATC

clonazepam; systemic

1.9

9.0

108

577

OAB42

NOMESCO Finland

Guidance related to known health problem

7.5

8.9

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

8.9

177

1096

L03.3

ICD-10 Finland

Cellulitis of trunk

3.9

8.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

8.9

768

6304

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

12.6

8.9

N06AA10

ATC

nortriptyline; systemic

2.6

8.8

196

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

6.8

8.8

JAH01

NOMESCO Finland

Laparoscopy

2.0

8.8

433

N06AB04

ATC

citalopram; systemic

1.4

8.8

386

2840

TQW40, ,

SPAT

1.6

8.8

198

1265

M10

ICD-10 Finland

Gout

2.1

8.8

386

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

8.8

282

R21

ICPC

Throat symptom/complaint

1.4

8.8

489

3750

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

8.8

110

595

L60.2

ICD-10 Finland

Onychogryphosis

10.7

8.8

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.0

8.8

441

H02BX01

ATC

methylprednisolone, combinations; systemic

2.1

8.8

414

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

8.7

174

1078

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

8.7

394

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.7

8.7

R55

ICD-10 Finland

Syncope and collapse

1.6

8.7

197

1261

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

8.7

252

RJ512, ,

NOMESCO Finland

14.1

8.7

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.8

8.7

140

819

QCH05

NOMESCO Finland

Correction of deformity of finger nail

50.2

8.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.4

8.7

240

A08AB01

ATC

orlistat; oral

4.3

8.7

QDB10, ,

SPAT

2.5

8.7

222

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

7.7

8.6

N48.1

ICD-10 Finland

Balanoposthitis

2.3

8.6

291

Z2446

NOMESCO Finland

Social worker

1.7

8.6

148

882

W19

ICD-10 Finland

Unspecified fall

1.6

8.6

202

1305

3025

Kela drug reimbursment

Calcium carbonate

4.8

8.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

8.6

324

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.9

8.6

131

N19

ICD-10 Finland

Unspecified kidney failure

2.3

8.5

292

212

Kela drug reimbursment

Gout

3.2

8.5

100

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

8.5

345

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.3

8.5

SPAT1255

SPAT

Intravenous administration of medicine

1.8

8.5

119

668

NH3DG

NOMESCO Finland

Very extensive MRI of foot

20.1

8.5

I50.0

ICD-10 Finland

Congestive heart failure

1.9

8.5

106

574

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

8.5

197

1270

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

8.4

181

1143

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

8.4

475

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

8.4

142

841

G04CA02

ATC

tamsulosin; oral

1.5

8.4

329

2369

6811B

ICD-9 Finland

Cellulitis and abscess of finger and toe, Toe[PARONYCHIA DIGITORUM PEDIS]

90.4

8.4

S21

ICPC

Skin texture symptom/complaint

1.5

8.4

290

2038

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.3

8.4

M79.1

ICD-10 Finland

Myalgia

1.5

8.4

317

2268

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

8.4

128

737

R03DC03

ATC

montelukast; oral

1.4

8.4

336

2431

R4180, ,

SPAT

3.3

8.3

M01AH02

ATC

rofecoxib; oral

1.6

8.3

209

1371

C10AA03

ATC

pravastatin; oral

1.8

8.3

117

657

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

8.3

348

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

8.3

283

XKD00

NOMESCO Finland

Uroflowmetry

1.6

8.2

221

1472

M01AX01

ATC

nabumetone; oral

2.1

8.2

356

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

8.2

149

901

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.1

8.2

363

H3603, E107,

ICD-10 Finland

14.5

8.2

J02AC02

ATC

itraconazole; systemic

1.5

8.2

319

2295

A12BA01

ATC

potassium chloride; oral

2.2

8.2

291

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

8.2

419

3167

UJF92

NOMESCO Finland

Capsular endoscopy

2.5

8.2

198

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

8.2

146

880

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.9

8.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

8.1

291

2059

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

8.1

490

3801

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

8.1

160

989

M01AX17

ATC

nimesulide; oral

1.4

8.1

408

3073

L08

ICPC

Shoulder symptom/complaint

1.4

8.1

451

3454

C08CA05

ATC

nifedipine; systemic

1.9

8.1

489

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

8.1

104

568

L03

ICPC

Low back symptom/complaint

1.3

8.1

606

4860

QDH

NOMESCO Finland

Operations on toe nails

17.2

8.1

RJ630, ,

NOMESCO Finland

17.2

8.1

H3603, E106,

ICD-10 Finland

11.7

8.1

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

11.7

8.1

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.8

8.1

122

701

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

8.0

114

642

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

8.0

171

1078

L15

ICPC

Knee symptom/complaint

1.4

8.0

504

3934

A10AA03, ,

ATC

3.7

8.0

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

8.0

428

3257

L13

ICPC

Hip symptom/complaint

1.4

8.0

344

2521

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.2

8.0

L21.0

ICD-10 Finland

Seborrhoea capitis

3.4

7.9

P01BA02

ATC

hydroxychloroquine; oral

1.7

7.9

147

894

L30.3

ICD-10 Finland

Infective dermatitis

2.1

7.9

348

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

7.9

330

2405

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

7.9

178

1139

R02

ICPC

Shortness of breath/dyspnoea

1.5

7.9

248

1710

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

4.6

7.9

R74

ICPC

Upper respiratory infection acute

1.3

7.8

743

6153

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

7.8

190

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.0

7.8

411

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

3.5

7.8

B02.9

ICD-10 Finland

Zoster without complication

1.8

7.8

124

723

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

7.8

177

1135

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.7

7.8

144

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

7.8

165

1040

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

7.8

298

R06.5

ICD-10 Finland

Mouth breathing

1.6

7.8

189

1232

G04BD12

ATC

mirabegron; oral

1.6

7.7

195

1281

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

7.7

259

1809

L73.2

ICD-10 Finland

Hidradenitis suppurativa

6.4

7.7

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.7

458

3545

SPAT1283

SPAT

Restricted health certificate

1.4

7.7

380

2853

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.9

7.7

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.5

7.7

180

M09AX01

ATC

hyaluronic acid; parenteral

2.0

7.7

380

M20.5

ICD-10 Finland

Other deformities of toe(s) (acquired)

4.0

7.6

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

7.6

240

1656

B01AB10

ATC

tinzaparin; parenteral

1.6

7.6

194

1278

M14.6

ICD-10 Finland

Neuropathic arthropathy

18.4

7.6

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

7.6

294

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

7.6

187

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

7.6

195

1287

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

7.6

485

3795

RS221, ,

NOMESCO Finland

2.8

7.6

135

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

7.5

516

L20.0

ICD-10 Finland

Besnier prurigo

1.6

7.5

169

1080

D06BX01

ATC

metronidazole; topical

1.6

7.5

174

1120

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

10.1

7.5

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

7.5

335

D01AC02

ATC

miconazole; topical

1.7

7.5

137

830

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

7.5

143

877

C09AA05

ATC

ramipril; oral

1.4

7.5

398

3023

OAB72, ,

SPAT

2.7

7.5

147

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

2.9

7.5

119

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.9

7.5

119

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

7.5

150

932

ZZA00

NOMESCO Finland

Split skin graft

2.4

7.5

219

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.4

7.5

219

R04.0

ICD-10 Finland

Epistaxis

1.7

7.5

130

778

S01

ICPC

Pain/tenderness of skin

1.9

7.5

518

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

7.4

323

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

7.4

213

1440

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.4

7.4

S70

ICPC

Herpes zoster

2.3

7.4

245

S82.0

ICD-10 Finland

Fracture of patella

2.7

7.4

142

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

7.4

531

4223

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

7.4

455

SFA00

NOMESCO Finland

Small restoration

1.5

7.4

282

2020

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

3.5

7.4

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.5

7.4

A01AB04

ATC

amphotericin B; local oral

2.0

7.4

399

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

7.4

111

637

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

7.4

520

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

7.4

202

1353

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

7.4

195

1296

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

7.3

442

R01AD12

ATC

fluticasone furoate; nasal

1.3

7.3

665

5465

SDA03

NOMESCO Finland

Periodontal treatment

1.3

7.3

842

7138

RJ520, ,

NOMESCO Finland

+∞

7.3

I50

ICD-10 Finland

Heart failure

2.4

7.3

203

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

7.3

302

2197

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

9.4

7.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

7.3

306

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

7.3

120

708

K92

ICPC

Atherosclerosis/periph vascular dis

3.4

7.2

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

2.3

7.2

216

M01CB01

ATC

sodium aurothiomalate; parenteral

3.3

7.2

M01AB05

ATC

diclofenac; systemic, rectal

1.3

7.2

1340

12025

K08.3

ICD-10 Finland

Retained dental root

1.6

7.2

148

925

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

7.2

229

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

7.2

199

1335

C09BA02

ATC

enalapril and diuretics; systemic

1.7

7.2

120

710

TK820

NOMESCO Finland

Peritoneal dialysis

4.5

7.2

C09DA01

ATC

losartan and diuretics; oral

1.6

7.2

182

1198

A10BX01

ATC

guar gum; oral

2.2

7.2

275

D05BB02

ATC

acitretin; oral

2.4

7.1

205

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

20.1

7.1

C08DB01

ATC

diltiazem; oral

2.0

7.1

356

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.6

7.1

151

M01AH01

ATC

celecoxib; oral

1.4

7.1

303

2215

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

7.1

263

1873

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

6.6

7.1

N20.1

ICD-10 Finland

Calculus of ureter

2.1

7.1

336

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.0

7.1

405

B01AA03

ATC

warfarin; systemic

1.5

7.1

260

1850

SPAT1325

SPAT

Vaccination

1.3

7.0

600

4885

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.1

7.0

290

SPAT1360

SPAT

Extensive global examination

1.7

7.0

117

692

H25.8

ICD-10 Finland

Other senile cataract

1.6

7.0

156

995

L91.0

ICD-10 Finland

Hypertrophic scar

2.9

7.0

107

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

7.0

568

4593

M22.4

ICD-10 Finland

Chondromalacia patellae

2.1

7.0

331

M05BA04

ATC

alendronic acid; oral

1.7

7.0

136

839

A03FA02

ATC

cisapride; oral, rectal

1.7

7.0

120

716

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

7.0

415

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.9

7.0

113

A10BX07

ATC

[U] liraglutide

3.0

6.9

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

6.9

395

A10AD05

ATC

insulin aspart; parenteral

2.8

6.9

119

SFA30

NOMESCO Finland

Three-surface restoration

1.3

6.9

844

7194

N05CD07

ATC

temazepam; oral

1.6

6.9

176

1161

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.3

6.9

215

R06.2

ICD-10 Finland

Wheezing

1.8

6.9

525

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.8

709

5919

WZC00, ,

SPAT

1.4

6.8

301

2213

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

6.8

504

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

6.8

126

767

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

6.8

149

947

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

6.8

215

1484

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.8

6.8

512

L68.0

ICD-10 Finland

Hirsutism

11.0

6.8

M01AH03

ATC

valdecoxib; oral

1.8

6.8

106

616

UJD02

NOMESCO Finland

Gastroscopy

1.9

6.8

419

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.7

6.8

126

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

6.7

144

910

N03AG01

ATC

valproic acid; systemic, rectal

1.7

6.7

121

731

J01AA07

ATC

tetracycline; systemic

1.4

6.7

279

2029

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

6.7

184

1232

C10AA04

ATC

fluvastatin; oral

1.7

6.7

127

778

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

6.7

456

3AC01, ,

NOMESCO Finland

3.4

6.7

S06.0

ICD-10 Finland

Concussion

1.5

6.7

215

1490

RJ120, ,

NOMESCO Finland

22.6

6.7

WX402

NOMESCO Finland

General anaesthesia

1.3

6.7

440

3453

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

6.7

103

597

J01MA01

ATC

ofloxacin; systemic

1.7

6.7

131

811

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

6.6

152

977

R25.1

ICD-10 Finland

Tremor, unspecified

2.1

6.6

277

H92.0

ICD-10 Finland

Otalgia

1.6

6.6

138

867

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

6.6

135

844

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

6.6

325

M65.3

ICD-10 Finland

Trigger finger

1.8

6.6

517

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.6

6.6

A10BK01

ATC

dapagliflozin; oral

1.6

6.6

138

868

A10AB06

ATC

insulin glulisine; parenteral

3.1

6.6

L01BB01, ,

ATC

12.3

6.6

G01AF05

ATC

econazole; vaginal

1.7

6.6

118

713

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.7

6.6

128

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.6

229

1612

N02AC04

ATC

dextropropoxyphene; oral

2.1

6.6

265

L04AB04

ATC

adalimumab; parenteral

2.2

6.6

226

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

6.5

292

A02BA03

ATC

famotidine; systemic

2.1

6.5

272

M54.1

ICD-10 Finland

Radiculopathy

1.9

6.5

403

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

6.5

347

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

6.5

167

1102

SPAT1285

SPAT

Provision of consultation response

1.8

6.5

556

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

6.5

119

723

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

6.5

148

951

N03AX09

ATC

lamotrigine; oral

1.7

6.5

106

625

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.2

6.5

K05.30

ICD-10 Finland

Periodontitis complex

1.4

6.5

275

2010

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

6.4

335

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

6.4

492

S90.2

ICD-10 Finland

Contusion of toe(s) with damage to nail

2.8

6.4

107

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

6.4

139

882

F29

ICPC

Eye symptom/complaint other

1.5

6.4

208

1444

R07.0

ICD-10 Finland

Pain in throat

1.6

6.4

152

986

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.4

6.4

178

SPAT1234

SPAT

Support of social functional capacity

1.8

6.4

493

R03BA01

ATC

beclometasone; inhalant

1.4

6.4

241

1723

A01AB09

ATC

miconazole; local oral

1.6

6.4

145

931

M01AC01

ATC

piroxicam; systemic, rectal

1.5

6.4

209

1454

P04

ICPC

Feeling/behaving irritable/angry

3.7

6.4

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

6.4

160

1052

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

6.3

516

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.9

6.3

436

M67.4

ICD-10 Finland

Ganglion

1.7

6.3

124

767

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

6.3

269

E000007, ,

ATC

1.7

6.3

104

614

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

6.3

606

5002

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

6.3

396

3083

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

6.3

394

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

6.3

218

1533

68104

ICD-8 Finland

Cellulitis of finger and toe, Unguis incarnatus infectus

11.0

6.3

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

6.3

1106

9800

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

6.3

570

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

6.3

416

H10

ICD-10 Finland

Conjunctivitis

1.6

6.3

155

1015

PFP99

NOMESCO Finland

Percutaneous plastic repair of artery of lower leg

18.1

6.3

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.9

6.3

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

6.2

325

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

6.2

325

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

6.2

519

A52.1

ICD-10 Finland

Symptomatic neurosyphilis

26.7

6.2

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

6.2

417

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

6.2

305

NH3AA, ,

SPAT

1.7

6.2

120

740

H02.4

ICD-10 Finland

Ptosis of eyelid

2.1

6.2

258

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

6.2

375

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

6.2

476

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

6.2

104

618

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.3

6.2

181

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

6.1

574

XKC03

NOMESCO Finland

Water cystometry

2.2

6.1

233

J01DA08

ATC

[U] cefaclor

1.4

6.1

235

1686

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

6.1

151

989

J46

ICD-10 Finland

Status asthmaticus

2.2

6.1

240

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

6.1

144

934

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

6.1

179

1219

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

6.1

162

1080

R06AE09

ATC

levocetirizine; oral

1.4

6.0

285

2120

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

6.0

407

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

6.7

6.0

NHS99

NOMESCO Finland

Other operation for infection of tendon, joint or bone of ankle or foot

10.0

6.0

RS340, ,

NOMESCO Finland

10.0

6.0

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

6.0

142

920

F34.1

ICD-10 Finland

Dysthymia

1.8

6.0

429

M05BA07

ATC

risedronic acid; oral

2.2

6.0

228

A10BB01

ATC

glibenclamide; oral

2.2

6.0

228

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

531

2323

2.67

77.51

2.3

1.7

—

(3000494) Fungus identified in Specimen by Culture

500

2456

2.32

54.82

1.8

1.5

—

(3023368) Bacteria identified in Blood by Culture

810

5023

1.94

46.76

5.2

4.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1492

11384

1.87

43.60

7.1

5.3

7.04

6.62

mmol/l

8.29

1427

10744

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1285

9475

1.80

40.80

11.9

7.4

1.21

mmol/l

0.30

1136

8236

(3042936) Bacteria identified in Isolate by Culture

500

2728

2.06

40.78

2.7

2.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

559

3211

1.98

39.28

4.2

2.6

12.42

13.63

umol/l

4.00

528

3006

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

789

5091

1.83

38.65

3.5

3.2

1731.49

1131.22

ng/l

1.52

686

4282

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1169

8479

1.76

38.36

10.4

6.9

1.21

mmol/l

0.05

1099

7879

(3004789) Transferrin [Mass/volume] in Serum or Plasma

526

2986

1.98

38.10

4.2

2.5

2.31

2.35

g/l

0.93

491

2764

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

491

2739

2.00

37.30

4.3

2.6

21.68

23.41

2.21

464

2566

(3024561) Albumin [Mass/volume] in Serum or Plasma

1152

8407

1.73

36.24

7.3

5.2

35.93

36.30

g/l

1.41

1091

7926

(3020682) Albumin/Creatinine [Ratio] in Urine

873

5955

1.75

34.48

5.6

4.2

14.83

8.51

mg/mmol

2.09

607

3783

(3026493) Urate [Moles/volume] in Serum or Plasma

764

5045

1.77

33.62

4.0

2.7

347.43

341.03

umol/l

0.91

683

4539

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1783

14882

1.85

33.60

11.1

8.0

79.74

78.53

u/l

0.50

1725

14166

(3032080) INR in Blood by Coagulation assay

1130

8317

1.70

33.51

16.8

13.1

1.21

inr

0.12

968

6936

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

757

4992

1.77

33.44

3.0

2.3

2.80

2.74

mg/l

0.33

671

4309

(3012516) Albumin [Mass/volume] in Urine

857

5859

1.73

33.29

4.8

3.6

76.25

47.33

mg/l

2.22

620

3816

(3002032) Base excess in Venous blood by calculation

363

1894

2.09

32.78

6.6

4.4

1.53

1.82

mmol/l

0.80

332

1630

(3021447) Carbon dioxide [Partial pressure] in Venous blood

371

1957

2.07

32.52

6.5

4.4

5.89

5.84

kpa

0.35

365

1902

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

515

3076

1.87

31.27

2.2

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

940

6678

1.68

31.13

4.7

3.5

7.61

7.99

mmol/l

1.63

811

5770

(3012544) pH of Venous blood

368

1965

2.04

31.10

6.3

4.4

7.37

7.38

0.69

223

1119

(3013115) Eosinophils [#/volume] in Blood

1367

10713

1.67

30.86

9.2

6.9

0.20

0.19

e9/l

1.31

1225

9418

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1194

9055

1.66

30.49

3.4

2.5

74.57

75.30

nmol/l

0.41

1087

8310

(3018418) pH of Serum or Plasma

825

5688

1.70

30.41

7.3

4.1

7.39

7.40

1.44

606

4086

(3006315) Basophils [#/volume] in Blood

1327

10385

1.65

29.53

9.1

6.7

0.04

e9/l

0.28

1172

8987

(3024354) Oxygen [Partial pressure] in Venous blood

321

1660

2.08

29.50

5.4

3.9

4.76

4.63

kpa

0.45

313

1611

(3001604) Monocytes [#/volume] in Blood

1323

10369

1.64

29.06

9.1

6.6

0.58

0.57

e9/l

0.49

1165

8972

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1291

10078

1.63

28.63

7.8

6.5

10.51

11.41

umol/l

2.79

1252

9615

(3000991) Gas panel - Venous blood

326

1721

2.04

28.27

9.4

10.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1524

12424

1.66

28.21

6.4

4.4

703.22

1885.59

e6/l

0.81

162

(3019198) Lymphocytes [#/volume] in Blood

1341

10632

1.62

27.36

9.1

6.7

1.83

1.95

e9/l

3.38

1209

9432

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

825

5813

1.65

27.27

2.7

2.2

160.36

248.86

u/l

2.39

785

5543

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

965

7075

1.62

27.15

4.6

3.5

42.69

42.26

ng/l

0.01

675

4618

(3020779) Urea [Moles/volume] in Serum or Plasma

323

1725

2.01

27.06

16.0

8.3

10.73

8.90

mmol/l

4.78

313

1659

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

859

6129

1.64

26.92

4.2

2.6

54.52

73.27

u/l

0.81

805

5705

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

283

1445

2.09

26.79

6.8

4.1

118.66

83.75

ng/l

4.24

249

1284

(3000850) Epithelial cells [#/volume] in Urine

635

4202

1.70

26.55

3.8

2.7

4.69

6.06

e6/l

2.29

587

3832

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1091

8274

1.60

26.46

2.4

2.0

96.36

96.86

pmol/l

0.12

578

4412

(3013650) Neutrophils [#/volume] in Blood by Automated count

1427

11559

1.61

26.01

12.5

9.9

4.27

4.02

e9/l

3.55

1266

10068

(3003458) Phosphate [Moles/volume] in Serum or Plasma

436

2610

1.83

25.76

13.4

6.3

1.10

1.06

mmol/l

2.06

410

2439

(3002582) Erythrocytes [#/volume] in Urine

857

6168

1.62

25.61

4.7

3.3

28.56

63.23

e6/l

2.02

690

4660

(3026250) Tacrolimus [Mass/volume] in Blood

109

4.95

24.41

44.6

41.4

7.43

7.41

ug/l

0.02

(3026008) Bacteria identified in Urine by Culture

767

5457

1.61

23.58

4.1

3.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

201

952

2.22

22.95

1.7

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

736

5236

1.59

22.39

1.9

1.7

19.81

20.29

nmol/l

0.39

634

4488

(3018095) Leukocytes [#/volume] in Urine

953

7204

1.55

22.15

5.5

3.9

50.94

91.13

e6/l

1.90

714

4963

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

384

2312

1.79

21.97

2.0

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

255

1349

2.00

21.74

1.9

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

717

5104

1.59

21.60

1.4

1.3

1.24

1.74

u/ml

1.07

199

1399

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

370

2218

1.79

21.44

2.1

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

843

6240

1.55

21.32

2.9

2.4

—

(3018010) Neutrophils/Leukocytes in Blood

1206

9658

1.52

21.05

9.1

6.7

57.98

56.54

4.32

1154

9258

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1220

9802

1.51

20.91

4.4

3.1

117.00

116.21

ug/l

0.05

1148

9235

(36304419) Bacteria [Presence] in Urine

717

5135

1.57

20.90

4.3

3.1

—

0.00

estimate

—

(3030467) Casts [#/volume] in Urine by Automated count

740

5348

1.56

20.69

4.4

3.2

0.28

0.37

e6/l

1.36

571

3872

(3019069) Monocytes/Leukocytes in Blood

1194

9565

1.51

20.65

9.4

6.9

8.73

8.79

0.33

1126

9003

(3012095) Magnesium [Moles/volume] in Serum or Plasma

496

3261

1.66

20.51

5.4

3.9

0.81

0.82

mmol/l

1.16

465

3104

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1139

9059

1.50

20.23

3.1

2.8

—

estimate

—

(3022096) Basophils/Leukocytes in Blood

1189

9542

1.50

20.21

9.3

6.9

0.66

0.69

0.83

1122

8975

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

670

4763

1.57

20.01

2.9

2.4

—

(3006504) Eosinophils/Leukocytes in Blood

1188

9547

1.50

19.96

9.3

6.8

2.88

2.84

0.29

1122

8980

(40758558) Short blood count panel - Blood

813

6039

1.53

19.90

8.3

6.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2140

19742

2.06

19.89

27.4

16.7

3.98

3.96

mmol/l

3.97

2114

19305

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

646

4568

1.57

19.69

2.1

1.8

1.14

1.13

mg/l

0.01

500

3446

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2139

19742

2.05

19.65

24.8

14.4

22.02

23.22

mg/l

1.03

1875

16009

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1676

14515

1.55

19.41

6.1

4.2

12.69

10.73

mm/h

6.14

1584

13642

(3021601) Nitrite [Presence] in Urine by Test strip

1272

10419

1.49

19.10

5.8

3.6

0.00

estimate

0.50

253

2155

(3003396) Base excess in Arterial blood by calculation

346

2102

1.76

19.01

7.5

9.2

0.56

0.89

mmol/l

0.69

292

1737

(3019309) Folate [Moles/volume] in Red Blood Cells

441

2867

1.66

18.88

1.9

1.7

1304.68

1174.04

nmol/l

1.88

332

2193

(3019550) Sodium [Moles/volume] in Serum or Plasma

2131

19685

1.99

18.87

27.3

16.6

139.54

139.67

mmol/l

1.74

2107

19292

(3002030) Lymphocytes/Leukocytes in Blood

1210

9831

1.48

18.80

9.3

6.8

27.12

28.63

5.40

1156

9357

(3009261) Glucose [Presence] in Urine by Test strip

1287

10587

1.48

18.77

5.8

3.7

0.02

0.16

estimate

0.46

236

2045

(3007164) IgA [Mass/volume] in Serum or Plasma

634

4508

1.56

18.69

1.5

2.29

2.34

g/l

0.28

386

2863

(3015736) pH of Urine

1069

8486

1.48

18.60

5.0

3.3

6.27

6.21

0.89

635

4838

(3010375) cycloSPORINE [Mass/volume] in Blood

4.73

18.47

33.5

30.6

103.19

128.33

ug/l

1.37

(3030981) Hyaline casts [#/volume] in Urine by Automated count

259

1453

1.88

18.46

3.2

2.5

0.42

0.49

e6/l

0.24

245

1385

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

211

1107

2.00

18.34

4.3

3.7

1.60

mmol/l

0.01

154

825

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

345

2115

1.74

18.32

7.6

9.2

5.02

5.10

kpa

0.99

336

2041

(3027801) Oxygen [Partial pressure] in Arterial blood

345

2116

1.74

18.28

7.6

9.2

12.32

12.51

kpa

0.22

337

2043

(3035350) Ketones [Presence] in Urine by Test strip

1278

10531

1.47

18.25

5.8

3.7

5.46

5.65

estimate

0.01

256

2191

(3019977) pH of Arterial blood

344

2116

1.73

18.03

7.7

9.2

7.42

0.48

197

1150

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2005

18240

1.72

17.83

6.5

5.2

1.82

1.87

mu/l

1.03

1886

17075

(3009343) pH of Capillary blood

230

1256

1.92

17.78

4.5

3.7

7.41

0.44

198

1052

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

233

1287

1.90

17.39

4.7

3.7

5.16

5.17

kpa

0.08

226

1243

(3018677) aPTT in Platelet poor plasma by Coagulation assay

443

2942

1.62

17.29

2.8

2.3

30.11

29.45

1.40

435

2861

(3016502) Oxygen saturation in Arterial blood

312

1889

1.75

17.25

7.7

9.7

95.82

95.79

0.03

306

1835

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1755

15501

1.54

17.21

5.1

4.3

14.79

14.70

pmol/l

0.79

1640

14343

(40768804) Tissue Pathology biopsy report

943

7417

1.46

16.59

2.4

2.0

—

(3033658) Prothrombin time (PT) actual/Normal

677

4999

1.50

16.36

5.4

4.3

91.94

91.14

0.34

659

4899

(3027945) Reticulocytes/Erythrocytes in Blood

332

2076

1.70

16.30

3.3

3.1

1.82

1.77

0.37

293

1880

(3015377) Calcium [Moles/volume] in Serum or Plasma

855

6618

1.46

16.27

4.1

3.4

2.35

2.36

mmol/l

0.97

779

6071

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

484

3333

1.57

16.10

3.7

2.9

1.27

1.04

e6/l

0.57

277

1713

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

892

6988

1.45

15.81

4.0

3.4

28.12

32.38

u/l

6.76

838

6627

(3037522) Nuclear Ab [Titer] in Serum

425

2882

1.58

15.01

1.4

494.85

497.77

titre

0.01

583

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

203

1128

1.88

14.84

1.6

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

298

1865

1.69

14.50

2.4

0.23

0.22

g/l

3.25

281

1744

(3021589) Normoblasts [#/volume] in Blood

1099

9036

1.41

14.48

15.4

11.2

0.00

e9/l

0.33

915

7393

(3048689) Calprotectin [Mass/mass] in Stool

416

2831

1.57

14.42

2.6

2.7

162.80

128.88

ug/g

0.65

332

2274

(3045414) Leukocytes [Presence] in Urine

285

1769

1.70

14.30

2.5

2.1

0.00

0.01

estimate

0.78

384

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2033

18799

1.65

14.10

21.5

13.7

84.36

86.05

ml/min/173m2

2.36

1889

17175

(3036481) Cortisol [Moles/volume] in Serum or Plasma

315

2020

1.65

13.93

2.6

2.2

358.93

378.99

nmol/l

1.15

294

1885

(3026782) Osmolality of Urine

512

3676

1.50

13.82

4.2

2.9

519.09

536.53

mosm/kgh2o

1.09

462

3233

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

486

3461

1.51

13.62

1.4

1.3

13.92

10.38

u/ml

0.45

208

1370

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

132

656

2.07

13.31

2.3

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

452

2.29

13.23

12.4

6.3

309.21

527.13

iu/ml

0.47

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

523

3808

1.48

13.09

1.9

1.7

41372119.63

29083482.30

pmol/l

0.16

452

3239

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

242

1471

1.72

13.07

3.4

2.6

62.12

71.26

ml/min/173m2

2.60

122

597

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

324

2132

1.60

12.86

5.0

4.6

232.96

241.52

u/l

0.72

309

2028

(3029937) Albumin [Presence] in Urine by Test strip

725

5629

1.42

12.84

6.4

3.8

0.00

0.01

estimate

1.79

238

2022

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

973

7962

1.38

12.58

5.7

3.5

0.00

0.03

estimate

2.32

213

1791

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

236

1457

1.69

12.02

2.7

2.4

6.16

7.98

ug/l

0.73

209

1300

(3023520) Reticulocytes [#/volume] in Blood

250

1569

1.66

11.97

3.4

3.0

71.48

71.45

e9/l

0.01

188

1145

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

207

1246

1.73

11.57

9.0

11.4

1.30

1.32

0.15

207

1239

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1976

18330

1.52

11.50

8.8

5.8

41.52

38.69

mmol/mol

24.85

1891

17351

(3017732) Neutrophils [#/volume] in Blood

363

2512

1.53

11.48

3.6

3.2

4.77

4.96

e9/l

0.12

308

2207

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

495

3653

1.45

11.37

3.2

2.9

2.44

mmol/l

0.13

450

3287

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

118

597

2.03

11.37

2.1

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

201

1206

1.73

11.36

9.2

11.8

0.66

0.64

0.47

201

1200

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

294

1955

1.58

11.10

4.1

2.5

34.11

63.43

u/l

0.63

244

1661

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2193

20911

1.86

10.97

16.8

11.3

28.18

27.71

u/l

0.52

2156

20384

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

403

2.23

10.96

1.6

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2201

21013

1.90

10.94

29.5

18.0

83.02

76.00

umol/l

7.21

2182

20786

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

334

2294

1.53

10.91

3.0

5.88

7.65

umol/l

2.49

289

2017

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

132

705

1.92

10.90

2.5

2.0

2.26

1.82

ug/l

0.19

121

629

(3009445) Proteinase 3 Ab [Units/volume] in Serum

148

823

1.85

10.80

1.5

1.6

29.90

11.20

iu/ml

—

(3019150) Specific gravity of Urine by Refractometry

606

4682

1.40

10.69

6.0

3.7

1.02

1.35

kg/l

0.50

418

3076

(3014007) Fractional oxyhemoglobin in Arterial blood

203

1243

1.69

10.65

9.3

11.6

93.96

94.07

0.11

203

1237

(3019060) Gas panel - Arterial blood

176

1042

1.75

10.43

5.3

—

(3052851) Hemolysis interference index of Serum or Plasma

103

514

2.05

10.32

3.4

3.0

2.92

2.07

index

0.68

267

(3000570) Elastase.pancreatic [Mass/mass] in Stool

115

598

1.97

10.28

1.6

1.4

252.17

287.72

ug/g

1.23

353

(3020630) Protein [Mass/volume] in Serum or Plasma

228

1453

1.63

10.26

2.5

2.8

65.48

66.83

g/l

2.13

214

1347

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

500

3767

1.42

10.13

1.4

1.3

42.52

27.64

iu/ml

0.73

138

1118

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

405

2.17

10.03

2.7

2.3

96.35

114.47

ug/min

0.20

243

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

424

3105

1.45

10.03

3.9

3.0

3.75

2.66

e6/l

1.03

215

1479

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

301

2059

1.53

9.98

10.2

6.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

104

528

2.02

9.96

1.5

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

486

3653

1.42

9.95

5.2

3.7

515.49

507.06

ng/l

0.01

370

2688

(3017181) Myelocytes/Leukocytes in Blood

265

1772

1.56

9.73

5.3

4.7

1.25

0.95

0.62

517

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

227

2.55

9.72

1.5

1.4

—

(3022313) Gas panel - Capillary blood

156

911

1.76

9.71

4.7

3.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

141

800

1.81

9.67

1.9

2.0

1.67

1.49

g/l

1.38

126

707

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

223

2.55

9.56

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

226

2.51

9.30

1.5

1.4

—

(4146454) Self-monitoring of blood glucose

180

2.70

9.24

3.6

2.8

—

(3045424) Erythrocytes [Presence] in Urine

154

914

1.73

9.07

2.6

2.1

0.00

0.86

estimate

0.51

296

(40768797) Stomach Pathology biopsy report

366

2656

1.45

9.02

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

3.53

8.80

4.8

4.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

217

2.48

8.57

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

217

2.48

8.57

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

218

2.46

8.49

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

128

735

1.78

8.46

4.9

4.1

24.70

24.77

mmol/l

0.10

119

691

(3021440) Promyelocytes/Leukocytes in Blood

249

1699

1.52

8.32

5.2

4.8

0.15

0.10

0.58

443

(3005719) IgG [Mass/volume] in Serum or Plasma

247

1685

1.52

8.26

3.7

2.9

10.25

10.60

g/l

0.76

232

1559

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

101

544

1.90

8.20

3.3

3.7

0.32

0.35

iu/ml

0.44

293

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

104

567

1.87

8.14

1.5

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

205

1348

1.57

8.09

8.6

10.5

24.58

24.93

mmol/l

0.70

205

1341

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1543

14016

1.30

7.94

3.5

3.2

—

(40768446) Kidney Pathology biopsy report

3.36

7.93

1.9

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

195

1277

1.58

7.84

3.5

4.48

4.61

pmol/l

0.69

176

1154

(36660697) Celiac disease serology panel - Serum

256

1779

1.49

7.84

1.2

—

(3025159) Blasts/Leukocytes in Blood

248

1723

1.49

7.60

5.6

5.0

0.00

0.12

3.21

405

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1958

18470

1.38

7.30

5.1

4.0

1.44

1.32

mmol/l

8.52

1848

17226

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1573

14391

1.29

7.29

3.7

3.3

51.07

46.30

u/l

1.40

1504

13694

(3014051) Protein [Presence] in Urine by Test strip

709

5885

1.29

7.23

3.6

2.8

0.09

0.02

0.34

107

(3004588) Protein electrophoresis panel - Serum or Plasma

179

1173

1.57

7.19

2.1

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2070

19747

1.44

6.93

6.6

5.3

2.61

2.77

mmol/l

14.21

1968

18601

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

119

711

1.71

6.90

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

371

2822

1.37

6.89

2.1

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

547

1.81

6.86

2.0

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

109

2.87

6.79

2.0

1.4

1.03

1.25

nmol/l

0.51

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2042

19449

1.41

6.74

5.9

4.7

1.37

1.43

mmol/l

9.54

1936

18291

(4035726) Immunohistochemistry procedure

224

1562

1.48

6.74

1.5

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

156

2.53

6.69

2.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

156

2.53

6.69

2.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

156

2.53

6.69

2.3

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

194

1318

1.51

6.63

1.8

1.9

1.34

1.32

g/l

0.05

173

1228

(3023420) DNA double strand Ab [Units/volume] in Serum

132

820

1.65

6.62

2.4

1.8

8.75

7.15

iu/ml

0.29

186

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

496

1.83

6.56

1.4

1.5

4.04

3.74

mmol/l

1.10

470

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

496

1.83

6.56

2.1

3.4

2.00

3.92

ratio

0.78

274

(3025941) Bacteria identified in Stool by Culture

169

1117

1.55

6.55

1.4

1.2

—

(3035941) MCH [Entitic mass]

2245

21846

1.81

6.42

35.6

21.6

30.10

30.24

3.29

2233

21638

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2245

21847

1.81

6.41

35.6

21.7

90.42

90.52

0.51

2233

21639

(3007461) Platelets [#/volume] in Blood

2244

21836

1.80

6.38

35.8

21.8

255.09

252.85

e9/l

0.89

2222

21426

(3026361) Erythrocytes [#/volume] in Blood

2245

21849

1.81

6.38

35.7

21.7

4.53

4.57

e12/l

2.84

2216

21390

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2245

21849

1.81

6.38

36.3

22.3

40.64

41.66

1.89

2233

21631

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

142

2.56

6.36

1.2

1.3

—

(4062490) Immunoglobulin typing, IgG

223

2.22

6.33

1.2

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

576

1.75

6.33

2.8

2.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2047

19542

1.40

6.32

6.0

4.8

4.50

4.68

mmol/l

14.59

1958

18491

(3010813) Leukocytes [#/volume] in Blood

2245

21855

1.80

6.28

35.8

21.8

6.84

6.66

e9/l

4.11

2219

21381

(3000963) Hemoglobin [Mass/volume] in Blood

2245

21855

1.80

6.28

36.0

21.9

135.38

137.29

g/l

7.38

2233

21650

(3005322) IgE [Units/volume] in Serum or Plasma

211

1475

1.47

6.28

1.4

1.3

289.57

213.58

u/ml

0.35

193

1374

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

446

1.85

6.22

2.0

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

439

1.85

6.21

1.9

1.5

131.67

147.80

au/ml

0.60

129

(3024139) IgG subclass 3 [Mass/volume] in Serum

225

2.20

6.21

1.2

1.3

0.44

0.39

g/l

0.39

163

(3027135) IgG subclass 1 [Mass/volume] in Serum

225

2.20

6.21

1.2

1.3

6.26

6.82

g/l

0.63

165

(3036489) Thrombin time

128

803

1.63

6.19

2.8

2.5

21.11

20.80

0.15

119

727

(40768443) Skin Pathology biopsy report

125

780

1.64

6.18

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

226

2.19

6.14

1.2

1.3

2.92

2.95

g/l

0.05

164

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

529

1.77

6.13

1.2

1.3

—

9.95

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

179

1216

1.51

6.13

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

300

2.03

6.11

1.3

—

(3002179) Metamyelocytes/Leukocytes in Blood

234

1680

1.44

6.06

5.5

4.6

0.59

0.68

0.13

477

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

547

1.75

6.02

2.4

3.6

43.43

46.64

mg/l

0.13

465

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

344

1.95

5.99

1.3

1.2

80.83

320.74

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

548

1.75

5.99

2.4

3.6

52.15

57.90

mg/l

0.20

467

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

141

2.50

5.95

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

520

1.76

5.92

1.4

1.3

201.03

243.57

u/ml

1.27

320

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

138

892

1.58

5.92

2.4

2.3

—

(3022145) Colonoscopy Study observation

298

2244

1.38

5.86

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1954

18567

1.33

5.82

5.9

4.7

6.25

5.87

mmol/l

16.72

1820

17222

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

111

683

1.66

5.81

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

102

614

1.69

5.80

1.1

2.71

3.91

1.23

101

(3024980) IgG subclass 4 [Mass/volume] in Serum

391

1.87

5.79

1.4

1.7

0.62

0.75

g/l

0.69

309

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

501

1.77

5.79

2.3

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

126

802

1.60

5.77

5.1

5.4

1.67

1.62

0.22

119

758

(3024932) HLA-DR beta [Type]

3.16

5.74

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

200

2.22

5.73

2.1

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

510

1.75

5.73

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

112

694

1.64

5.71

5.7

5.2

1.65

1.38

mg/l

2.27

105

640

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

186

1294

1.48

5.68

1.3

42.97

50.61

au/ml

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

162

1096

1.51

5.67

1.1

—

0.89

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

475

1.78

5.65

2.0

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

366

1.88

5.63

2.1

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.20

5.59

3.8

2.9

0.60

0.62

mmol/l

0.62

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

383

1.85

5.52

1.1

145.36

1571.50

iu/ml

0.49

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

572

1.69

5.42

1.3

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1801

16976

1.27

5.39

28.0

17.9

13.70

13.47

10.61

1787

16749

(40760892) CBC W Ordered Manual Differential panel - Blood

571

4759

1.26

5.38

6.8

4.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

469

3816

1.29

5.37

2.0

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

111

701

1.61

5.27

3.0

2.7

97.08

93.74

0.92

106

685

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

516

1.71

5.25

2.3

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

196

1401

1.44

5.22

2.5

2.4

20.28

19.79

au/ml

0.02

162

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

204

1469

1.43

5.21

7.3

3.8

1.23

mmol/l

0.44

184

1278

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

487

1.73

5.21

1.6

1.5

158.31

33.29

e6/l

0.42

354

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

417

1.77

5.04

1.1

21.18

17.14

au/ml

0.12

118

(3048929) Epstein Barr virus Ab [Presence] in Serum

133

886

1.53

5.03

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

464

1.73

4.96

7.7

2.0

0.95

0.88

nmol/l

0.33

403

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

944

8366

1.22

4.95

2.2

1.9

1.52

1.41

mmol/l

2.60

815

7238

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

261

1.98

4.94

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

495

1.70

4.93

1.7

1.6

5408.14

1104.85

e6/l

0.43

379

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

137

924

1.51

4.90

2.4

2.0

37.82

39.85

u/l

0.54

125

837

(3014765) Yersinia sp identified in Stool by Organism specific culture

581

1.64

4.89

1.3

1.2

—

(3024471) HLA-A [Type]

2.93

4.87

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.93

4.87

1.5

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

175

2.19

4.85

2.3

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

249

1.99

4.85

2.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

585

1.63

4.77

1.3

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

336

1.84

4.76

1.3

—

8.70

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

3.42

4.74

1.1

0.70

7.16

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

547

4596

1.25

4.74

1.8

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

109

2.49

4.63

1.5

1.2

93.89

84.01

u/l

0.19

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

193

2.09

4.56

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

201

2.06

4.49

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

111

2.45

4.47

3.6

3.7

0.96

0.88

index

0.22

111

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

448

1.70

4.46

1.4

1.2

20.33

51.16

u/ml

—

(44790049) Parainfluenza type 3 nucleic acid detection

264

1.91

4.46

2.2

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

264

1.91

4.46

2.2

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

264

1.91

4.46

2.2

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

264

1.91

4.46

2.2

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

550

1.62

4.41

1.4

1.2

5.59

2.51

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

189

2.08

4.41

1.3

1.2

75.97

57.98

u/l

0.31

172

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

108

709

1.55

4.40

1.6

1.5

0.05

0.12

iu/ml

0.50

117

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

375

1.75

4.38

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

375

1.75

4.38

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

150

2.22

4.37

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

157

2.18

4.34

1.4

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

347

1.78

4.32

1.3

1.2

2.34

4.01

u/ml

1.44

161

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

585

1.60

4.31

1.4

1.2

13.70

43.85

u/ml

—

(3002256) Pathology report gross observation

305

2414

1.30

4.28

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.97

4.28

1.1

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

247

1898

1.34

4.27

1.6

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.85

4.22

1.6

1.3

16.04

15.76

pmol/l

0.05

(3008757) Leukocyte morphology finding [Identifier] in Blood

179

2.08

4.21

4.3

3.9

—

(3044290) Cell count panel - Cerebral spinal fluid

456

1.67

4.20

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

373

1.74

4.18

2.1

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.90

4.13

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

552

1.60

4.12

1.4

1.3

5.45

9.21

u/ml

0.55

(3023419) Bacteria identified in Sputum by Culture

250

1.90

4.12

3.1

3.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

154

2.16

4.12

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

161

2.13

4.10

1.4

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

115

780

1.50

4.06

1.5

1.6

12.61

13.00

u/ml

0.02

188

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

197

1475

1.37

4.05

1.6

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

162

2.12

4.04

1.4

1.1

—

(3019225) pH of Specimen

219

1669

1.34

4.01

7.6

4.1

7.37

7.35

1.04

159

1223

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

10.03

4.01

5.6

5.3

521.71

425.86

umol/l

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

364

1.72

3.96

1.8

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.83

3.95

1.4

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

350

1.73

3.93

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

164

2.09

3.92

1.4

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

178

1319

1.38

3.90

3.0

2.9

240.43

180.76

ng/l

0.92

164

1194

(3007930) Methemoglobin/Hemoglobin.total in Blood

108

730

1.50

3.89

5.3

5.8

0.80

0.90

2.14

102

687

(3003327) Ova and parasites identified in Stool by Light microscopy

111

757

1.49

3.83

1.6

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

603

1.55

3.82

1.9

2.4

10.16

10.17

g/l

0.01

551

(3028433) Virus identified in Specimen by Culture

2.85

3.79

1.4

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

462

1.62

3.77

2.7

2.2

129.77

131.14

g/l

0.18

375

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

280

1.80

3.77

1.7

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

332

1.73

3.76

2.6

1.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

108

2.33

3.76

1.4

1.2

20.80

17.08

u/l

0.30

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.74

3.75

1.2

1.1

101.56

90.40

—

(3017569) Oxygen content in Arterial blood

2.41

3.72

2.8

2.5

14.48

16.34

2.72

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

168

2.04

3.70

1.4

1.1

—

(4195642) Thrombophilia screening test

320

1.74

3.65

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

169

2.03

3.65

3.6

3.4

16.11

12.86

index

0.91

111

(3015171) Extractable nuclear Ab [Units/volume] in Serum

112

774

1.47

3.64

1.3

1.2

0.29

0.70

u/ml

0.62

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.87

3.63

2.4

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

413

1.64

3.61

1.4

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

153

1122

1.39

3.59

1.6

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

352

1.69

3.59

1.3

1.2

2.00

3.52

u/ml

1.03

124

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.46

3.55

1.1

4.8

48.20

78.57

mg/l

1.77

(3014148) Varicella zoster virus Ab [Titer] in Serum

323

1.72

3.55

1.1

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.51

3.54

3.5

2.2

67.20

64.55

ug/l

0.06

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.51

3.54

4.1

3.6

1.53

1.29

0.24

(3037121) Protein [Mass/volume] in Urine

101

688

1.49

3.53

5.0

3.7

304.75

387.53

mg/l

0.39

330

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

257

1.81

3.51

2.2

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

3.63

3.49

1.8

2.1

—

(40768441) Liver Pathology biopsy report

153

2.04

3.41

1.3

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.09

3.39

16.4

7.6

5.22

6.90

mmol/l

1.03

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

157

2080

0.74

3.38

1.5

1.7

3.42

3.51

mmol/l

0.38

109

1405

(3023183) Ammonium ion [Moles/volume] in Plasma

437

1.60

3.36

2.1

3.2

32.73

35.27

umol/l

0.38

401

(4024509) Urine culture

119

846

1.43

3.35

2.1

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

168

1.98

3.34

1.2

1.1

103.91

106.45

pmol/l

0.12

168

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

236

1871

1.29

3.30

3.9

3.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

122

2.14

3.26

1.4

30.00

17.55

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

286

1.73

3.25

2.3

2.5

10.88

34.26

iu/ml

—

(3034426) Prothrombin time (PT)

2.48

3.13

1.2

29.44

28.32

0.27

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

526

1.52

3.11

1.9

2.4

0.02

g/l

0.01

475

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.44

3.10

1.3

2.6

1.19

1.21

mmol/l

0.50

(3000475) Leukocytes [#/volume] in Synovial fluid

463

1.55

3.08

1.8

1.7

15350.80

12107.21

e6/l

0.31

326

(3041096) Erythrocytes [Presence] in Urine by Automated

664

5897

1.18

3.08

4.6

3.1

0.00

0.06

estimate

1.15

217

1722

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

585

1.49

3.07

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

176

1355

1.32

3.06

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.44

3.04

1.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.51

3.04

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.51

3.04

1.8

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

147

1.99

3.00

1.3

0.51

0.56

ratio

0.61

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

689

1.44

2.97

2.1

2.4

7.20

7.30

g/l

0.26

639

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.64

2.96

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.84

2.92

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

546

4793

1.18

2.89

2.4

2.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.60

2.87

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

171

1.88

2.86

4.0

3.2

57.48

55.41

0.22

153

(21494890) Protein electrophoresis panel - 24 hour Urine

164

1.90

2.85

1.5

1.9

—

(3037756) Immunofixation for Serum or Plasma

368

1.59

2.85

1.5

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

165

1.89

2.81

1.4

19973.28

90294.32

e6/l

0.95

112

(3003181) Sodium [Moles/volume] in Urine

338

1.61

2.81

1.5

1.4

63.12

64.28

mmol/l

0.08

275

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

689

1.43

2.80

2.1

2.4

3.79

3.72

g/l

0.16

639

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

689

1.43

2.80

2.1

2.4

4.17

4.26

g/l

0.50

638

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

515

1.49

2.79

1.8

2.4

0.01

0.00

g/l

0.49

450

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

110

2.10

2.78

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

2.70

1.1

1.3

—

(4268621) Lupus anticoagulant assay

249

1.70

2.69

2.5

2.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

168

1.86

2.67

1.4

1.66

1.75

u/ml

0.02

(3016018) Differential panel - Cerebral spinal fluid

242

1.71

2.67

2.0

1.6

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

205

1.77

2.65

1.6

1.7

64.36

59.82

0.32

133

(1616796) Gas panel - Central venous blood

415

1.53

2.65

4.8

3.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

133

1.97

2.65

1.2

1.1

0.32

2.43

u/ml

0.79

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

328

1.60

2.64

1.2

1.1

2.71

2.45

0.08

(3010838) Calcium [Moles/time] in 24 hour Urine

360

1.57

2.63

2.2

2.1

5.25

5.21

mmol/24h

0.03

319

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1803

17359

1.17

2.62

30.1

18.1

331.84

333.38

g/l

6.53

1796

17259

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.66

2.62

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

598

1.44

2.60

2.1

2.5

0.74

1.05

g/l

0.45

524

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.74

2.54

1.2

1.4

90.92

92.61

0.07

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.47

2.54

3.8

3.6

—

(3026480) Teichoate Ab [Titer] in Serum

5.47

2.54

1.0

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.23

2.54

1.5

1.3

100.78

504.69

u/l

1.84

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

226

2746

0.80

2.52

1.7

1.9

3.77

3.65

ratio

0.69

172

2083

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

194

1.76

2.51

1.3

1.2

48.96

40.11

mg/l

0.42

156

(3004809) Band form neutrophils/Leukocytes in Blood

286

1.62

2.49

4.1

3.5

1.28

1.52

0.21

263

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.39

2.46

1.3

1.5

97.38

88.76

—

(3000330) Specific gravity of Urine by Test strip

118

888

1.35

2.45

4.7

3.3

1.02

ratio

1.23

110

809

(3047181) Lactate [Moles/volume] in Blood

539

1.44

2.44

5.3

6.6

1.27

mmol/l

0.02

474

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.01

2.40

3.2

3.9

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.40

5.7

4.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

104

2.03

2.36

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

184

1.75

2.32

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

2.01

2.31

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.49

2.27

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

193

1.72

2.26

1.8

1.5

27.98

32.74

g/l

1.48

174

(3004775) Volume in Urine collected for unspecified duration

127

1.90

2.26

2.7

2.3

786.07

611.10

0.91

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

127

1.90

2.26

1.1

1.5

5.76

6.45

u/l

0.39

108

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

650

1.38

2.25

2.2

2.4

2.95

2.93

g/l

0.11

600

(21494814) CD8 cells/Lymphocytes in Specimen

2.16

2.24

2.5

1.8

30.59

30.58

0.00

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

186

1.73

2.24

1.1

317.04

257.56

mg/l

0.59

158

(3014599) Egg white IgE Ab [Units/volume] in Serum

142

1.84

2.23

1.2

1.1

0.38

1.22

u/ml

—

(21494755) Public health laboratory ask at order entry panel

201

2437

0.81

2.21

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.05

2.21

1.7

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

1.97

2.20

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.42

2.19

1.2

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

2.18

3.7

2.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.03

2.16

1.7

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

118

907

1.32

2.15

2.5

2.4

2050.51

5608.88

u/l

1.73

375

(3003329) Lymphocytes/Leukocytes in Synovial fluid

144

1.81

2.14

2.0

1.5

30.70

32.14

0.08

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.79

2.13

1.0

1.1

112.87

67.68

ug/l

—

(1002224) Polysomnography panel

148

1175

1.28

2.13

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

397

1.47

2.10

5.1

4.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.21

2.09

1.1

1.7

5.39

5.27

nmol/l

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

138

1.82

2.09

2.9

43.07

41.71

0.12

(3023199) Leukocytes [#/volume] in Pleural fluid

176

1.71

2.06

1.9

1.4

1597.96

1926.50

e6/l

0.21

117

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

207

1.65

2.04

2.0

2.2

17.75

22.09

mg/l

0.36

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.18

2.04

1.3

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

223

1.62

2.03

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

155

1.75

2.00

2.7

2.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

639

1.36

1.99

2.6

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

137

1088

1.28

1.98

1.9

1.8

0.23

0.33

mg/l

1.68

530

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

582

1.37

1.93

1.7

2.1

3.44

13.64

iu/l

0.55

246

(3009466) Valproate [Moles/volume] in Serum or Plasma

347

1.48

1.93

5.0

6.2

357.48

374.31

umol/l

0.36

311

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

256

2182

1.19

1.92

5.8

4.6

33.28

31.47

1.49

180

1500

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

165

1.71

1.91

5.7

2.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.25

1.90

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

381

1.45

1.90

3.8

2.5

16.38

16.59

0.22

373

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.31

1.87

5.4

3.1

5.07

4.87

kpa

0.31

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.31

1.87

5.4

3.1

9.96

10.14

kpa

0.16

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

268

1.54

1.87

2.3

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

629

1.35

1.87

1.2

1.3

82.50

96.39

titre

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

345

3023

1.17

1.86

2.0

1.9

1.42

1.45

0.35

309

2690

(44806071) Cardiolipin IgM antibody measurement

2.86

1.86

1.0

—

(40757373) Influenza virus identified in Isolate

2.58

1.80

3.3

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

177

1467

1.22

1.78

1.2

99.42

141.58

u/ml

1.02

541

(3022621) pH of Urine by Test strip

185

1541

1.22

1.78

3.4

2.4

6.05

6.09

0.26

127

1027

(3020876) Protein [Mass/time] in 24 hour Urine

209

1.59

1.74

3.3

2.6

2.11

1.31

g/24h

0.65

133

(3000093) Morphology [Interpretation] in Blood Narrative

178

1.64

1.73

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

110

1.83

1.73

1.1

1.3

137.15

140.67

nmol/l

0.13

110

(3005011) Chlamydia sp Ab [Titer] in Serum

2.67

1.72

1.5

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.92

1.72

3.4

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.92

1.72

1.4

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.92

1.70

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

589

1.34

1.67

1.1

2.80

6.11

eliau/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

149

1.69

1.67

1.9

1.4

13967.76

73977.27

e6/l

0.79

(3047007) Chlamydophila sp Ab [Presence] in Serum

342

1.44

1.66

1.3

1.2

—

(3016750) Collection duration of Urine

1.86

1.66

2.1

2.2

505.73

501.60

min

0.06

(1761868) Lipid panel - Serum or Plasma

794

8502

0.90

1.65

3.4

2.9

—

(4034850) Laboratory test

564

1.34

1.65

9.8

9.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.90

1.65

1.2

1.4

140.65

166.85

mmol/24h

0.82

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.98

1.64

2.0

2.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

596

5467

1.12

1.63

4.5

1.72

2.13

ug/l

1.14

545

4999

(3044242) Glucose [Moles/volume] in Arterial blood

105

1.82

1.63

3.2

2.2

9.43

8.27

mmol/l

0.56

105

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.15

1.61

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.15

1.61

2.3

3.1

—

(3023410) Appearance of Cerebral spinal fluid

230

1.53

1.60

2.3

1.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.91

1.59

1.8

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

134

1094

1.24

1.58

1.2

1.1

193.57

150.64

titre

—

(3038515) Glucose [Moles/volume] in Venous blood

347

1.42

1.56

4.2

3.1

8.14

7.55

mmol/l

0.55

334

(3023511) Choriogonadotropin [Units/volume] in Urine

450

1.37

1.54

1.6

1.3

—

(3045788) Cell count panel - Pleural fluid

153

1.64

1.53

2.0

1.4

—

(3035715) Granulocytes [#/volume] in Blood

374

1.40

1.52

3.5

3.6

4.56

4.01

e9/l

0.79

374

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

1.52

2.4

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

330

2930

1.15

1.51

1.6

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.83

1.51

4.6

2.1

—

29.71

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.86

1.50

7.5

4.0

0.22

0.19

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.07

1.49

3.1

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

672

1.29

1.48

3.0

3.7

6106.65

2294.61

u/ml

0.38

589

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.23

1.46

1.0

—

(3010421) pH of Blood

613

1.30

1.44

4.7

3.8

7.40

7.41

0.22

607

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

110

1.73

1.43

1.6

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

632

1.29

1.42

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

1.67

1.40

1.6

—

(3042631) Mycobacterium sp identified in Specimen

238

1.48

1.39

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

407

1.36

1.39

1.5

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

247

1.46

1.38

1.2

1.3

—

nmol/l

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.20

1.37

1.0

6.52

7.48

mg/g

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.83

1.35

1.2

—

(44813793) Dust mix specific IgE antibody measurement

143

1.61

1.35

1.2

1.0

—

(3003694) ABO and Rh group [Type] in Blood

652

6068

1.10

1.35

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

183

1.54

1.34

1.1

1.4

9.39

8.74

mmol/l

0.35

177

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

1.34

0.0

1.4

—

7.39

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

198

1710

1.17

1.33

4.1

4.4

5.59

21.88

ug/l

2.11

154

1388

(3026470) Cobalt [Mass/volume] in Blood

1.78

1.33

2.4

2.2

2.04

3.00

ug/l

0.74

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

782

1.25

1.32

1.4

1.3

217.98

226.76

miu/ml

0.08

363

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

184

1.53

1.32

1.2

1.1

25.20

16.51

u/ml

0.61

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

225

1.47

1.31

1.2

1.3

—

(3049717) Cytology report of Urine Cyto stain

578

1.29

1.30

1.8

2.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

121

1.66

1.30

1.5

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.30

1.0

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

2.78

1.28

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.94

1.27

1.3

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

115

1.66

1.24

1.6

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

100

1.71

1.23

2.2

3.2

40.33

127.41

umol/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.00

1.23

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

147

1.57

1.23

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.77

1.23

3.1

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.77

1.23

3.1

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.77

1.23

3.1

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.77

1.23

3.1

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1138

0.81

1.21

1.5

1.6

883.65

1007.85

mu/l

0.99

977

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

124

1.62

1.20

1.0

1.1

1581.11

1469.76

miu/ml

0.14

124

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

247

1.42

1.19

1.1

1.3

0.28

0.25

nmol/l

0.09

199

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

2.00

1.16

1.5

1.8

—

103.61

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

102

1.67

1.16

6.2

7.5

1.44

181.46

ug/l

—

(3008898) HLA-B27 [Presence]

806

1.23

1.15

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.73

1.15

1.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

1.62

1.14

1.9

1.7

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

158

1.52

1.14

2.9

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

528

0.73

1.12

1.6

1.7

—

(4198724) Urine methamphetamine measurement

143

1.54

1.11

3.3

3.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1082

0.82

1.11

1.7

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

469

4336

1.10

1.11

4.0

3.8

23.33

21.24

1.35

189

1715

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.79

1.10

4.3

5.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

334

3034

1.12

1.10

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.26

1.10

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

612

1.25

1.09

1.5

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.95

1.08

1.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.95

1.08

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.87

1.07

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.76

1.06

1.1

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.93

1.06

1.3

—

0.31

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

121

1.57

1.05

10.9

8.2

5870.38

235.76

u/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

154

1.50

1.03

2.0

2.6

631.72

600.06

e6/l

0.10

123

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.28

1.03

1.0

1.1

0.02

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.84

1.02

1.5

1.4

12.94

9.07

ug/l

1.03

(3008295) Osmolality of Serum or Plasma

238

1.39

1.02

2.1

1.3

284.15

279.20

mosm/kgh2o

0.63

174

(3009214) Lutropin [Units/volume] in Serum or Plasma

818

1.21

1.02

1.6

1.5

10.16

7.74

u/l

0.88

663

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.92

1.02

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.92

1.02

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.92

1.02

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.77

1.00

1.1

1.0

0.23

1.67

u/ml

0.58

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.18

0.98

1.0

4.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.18

0.98

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.97

0.0

2.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

422

0.73

0.96

1.4

1.5

64.31

59.44

ug/l

0.21

422

(3019832) Treponema pallidum Ab [Presence] in Serum

290

2639

1.11

0.95

2.1

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.95

0.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

191

1.42

0.94

1.7

1.5

1.86

1.37

promille

0.70

156

(3014271) Vancomycin [Susceptibility]

1.78

0.94

2.4

2.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

516

1.25

0.94

1.1

5.47

5.57

u/ml

0.02

299

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

260

1.35

0.93

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

580

1.23

0.93

1.1

2.93

2.82

u/ml

0.02

320

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.82

0.92

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.82

0.92

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.82

0.92

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.82

0.92

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.15

0.91

1.3

1.9

7.30

7.49

mmol/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

110

1.55

0.90

2.8

2.1

110.35

99.58

ng/l

0.16

110

(1175426) CD3 cells/Lymphocytes in Blood

168

1.43

0.89

2.3

2.2

71.29

73.67

0.28

161

(40761995) Spermatozoa Progressive [#/volume] in Semen

101

0.49

0.89

2.0

3.1

48.20

43.84

—

101

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

101

0.49

0.89

4.0

6.3

7.20

7.72

—

101

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

185

1.41

0.89

5.1

3.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

177

1.42

0.88

1.9

1.5

13.60

12.12

umol/l

0.48

165

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

483

0.76

0.88

1.8

—

(3024263) Appearance of Synovial fluid

1.61

0.87

2.0

1.7

—

(3017704) Immunofixation for Urine

1.58

0.87

1.4

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.82

0.86

30.9

6.7

9.19

5.21

kpa

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

1.50

0.85

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

213

1.37

0.84

1.2

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.57

0.84

1.1

1.2

212.51

216.76

iu/ml

0.02

(1617658) Protocol used for examination of sentinel lymph nodes

138

0.58

0.83

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

171

1.41

0.83

2.6

2.7

27.88

31.83

mg/l

0.18

123

(1001926) Buprenorphine [Presence] in Urine by Screen method

123

1072

1.16

0.82

1.8

2.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.55

0.81

1.3

1.1

—

(3035880) pH of Pleural fluid

1.61

0.81

1.3

7.29

7.38

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

303

1.29

0.79

2.6

2.2

4.90

5.68

umol/l

0.29

226

(3023323) Follitropin [Units/volume] in Serum or Plasma

124

1084

1.15

0.79

1.6

1.5

21.79

22.34

iu/l

0.07

101

905

(3028717) Thiamine [Mass/volume] in Blood

1.82

0.79

1.3

73.50

65.33

ug/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

182

1.38

0.78

4.1

5.0

40.77

56.93

u/ml

—

(40768806) Pleura Pathology biopsy report

148

1.42

0.77

2.0

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.70

0.75

1.7

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

0.74

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.84

0.73

1.3

1.1

—

(3048879) Bone marrow aspiration report

1.84

0.73

2.1

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.84

0.73

1.7

1.6

—

(3012441) Differential panel - Pleural fluid

150

1.40

0.73

2.0

1.5

—

(3020491) Glucose [Moles/volume] in Blood

150

1.40

0.73

1.9

1.6

8.27

6.61

mmol/l

1.05

103

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

106

0.56

0.72

1.5

2.4

106.00

142.46

nmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.62

0.71

2.1

22.47

16.25

umol/l

0.47

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.75

0.71

1.0

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.93

0.70

1.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

381

1.24

0.70

1.6

1.5

0.25

0.41

nmol/l

1.62

295

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

651

0.83

0.69

1.5

1.6

55.87

60.18

ug/l

0.35

560

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

152

1.39

0.69

1.8

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.85

0.68

2.8

1.7

—

(3042517) Benzodiazepines panel - Urine

1.85

0.68

1.2

2.3

—

(37021550) Renin [Units/volume] in Plasma --upright

1.67

0.68

1.6

1.2

47.40

65.51

mu/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.53

0.68

1.6

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.49

0.66

1.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

120

1.42

0.64

4.6

3.1

1021.59

893.06

u/ml

0.12

120

(3004616) Nuclear Ab [Presence] in Serum

233

1.29

0.64

1.2

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

496

1.19

0.64

1.2

1.1

0.35

1.48

u/ml

2.10

238

(3035933) Granulocytes/Leukocytes in Blood

478

1.20

0.63

3.5

3.4

59.01

57.37

0.49

478

(3020650) Glucose [Presence] in Urine

1.55

0.62

1.5

1.7

0.00

0.04

estimate

0.49

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.63

0.62

1.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.59

0.61

4.0

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.59

0.61

4.0

1.9

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.67

0.61

1.0

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

361

1.22

0.61

1.1

1.0

0.39

0.26

u/ml

0.13

125

(3044927) Protein electrophoresis panel - Urine

174

1.33

0.60

1.1

—

(3006462) Nitrate [Presence] in Urine

1.53

0.59

2.1

3.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

210

1.29

0.58

1.8

2.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.56

0.58

4.0

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

829

1.14

0.58

1.6

1.4

—

(3006270) Folate [Moles/volume] in Blood

132

1.37

0.57

1.2

1.1

424.77

400.48

nmol/l

0.15

122

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.62

0.55

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

385

1.20

0.54

1.1

3.91

5.76

u/ml

0.51

191

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

459

1.18

0.54

1.1

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

151

1.33

0.54

15.9

12.9

0.57

0.62

mmol/l

0.33

139

(40765089) Chromosome analysis panel - Blood by G-banded

0.61

0.52

1.2

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.50

0.51

1.5

1.2

0.10

1.52

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

230

2151

1.08

0.48

2.7

2.4

12.43

13.95

nmol/l

2.04

208

2003

(3014133) Dog dander IgE Ab [Units/volume] in Serum

410

1.17

0.47

1.1

2.64

4.12

u/ml

0.62

219

(3011288) Drugs identified in Urine by Screen method Nominal

102

920

1.11

0.47

2.6

3.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

155

1.29

0.46

1.0

1.1

1.03

1.06

u/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

590

0.86

0.46

1.5

—

(3025130) Human papilloma virus identified in Specimen

301

1.20

0.45

1.7

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

302

1.20

0.44

1.2

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

349

1.18

0.43

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

104

1.35

0.43

1.0

1.2

137.00

83.89

u/l

0.32

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

104

1.35

0.43

1.0

1.2

65.86

23.66

u/l

0.41

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

1.56

0.42

2.4

1.8

0.80

3.05

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

212

1.23

0.42

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

5.6

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.59

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1014

0.90

0.41

1.1

1.43

1.50

g/l

2.04

1014

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

105

1.34

0.41

1.4

1.3

15.21

13.18

u/l

0.30

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

47.29

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.39

0.40

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

960

0.90

0.40

1.1

0.61

0.66

ratio

—

(3028707) Methadone [Presence] in Urine by Screen method

579

1.13

0.39

2.4

3.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

506

0.87

0.39

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.3

—

31.84

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

160

1.25

0.38

1.3

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

151

1.26

0.38

1.3

1.2

—

57.00

—

(4211845) Urine protein measurement

1.38

0.38

2.1

3.2

—

(3027008) Opiates [Presence] in Urine

146

1361

1.08

0.36

1.8

2.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

598

0.88

0.36

1.5

1.30

1.20

ratio

0.34

372

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

598

0.88

0.36

1.5

1.26

1.14

ratio

0.36

371

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

598

0.88

0.36

1.5

0.98

0.96

ratio

0.16

371

(3027944) Amphetamines [Presence] in Urine

144

1344

1.08

0.35

1.7

2.2

—

(40768800) Prostate Pathology biopsy report

277

0.83

0.35

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.40

0.35

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

346

3321

1.05

0.35

3.0

2.8

0.62

0.71

ug/l

1.73

203

1823

(3028300) Cannabinoids [Presence] in Urine

146

1365

1.07

0.34

1.8

2.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

172

1.22

0.34

1.1

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

387

1.14

0.33

4.2

4.3

8.60

8.69

kpa

0.13

381

(3039443) Prostate specific Ag panel - Serum or Plasma

414

0.87

0.33

1.6

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

492

1.12

0.33

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

492

1.12

0.33

1.1

—

(3005033) Fetal Nuchal fold Thickness US

487

0.88

0.32

1.5

1.30

1.28

0.09

361

(3036782) Glucose [Moles/volume] in Pleural fluid

164

1.22

0.32

1.9

1.4

6.86

6.32

mmol/l

0.33

154

(3045142) Bone marrow Pathology biopsy report

231

0.82

0.32

1.1

1.3

—

(3000012) Reticulocyte production index

238

1.18

0.32

1.5

2.2

0.98

0.91

0.29

166

(3047352) Trisomy 18 risk [Likelihood] in Fetus

496

0.88

0.31

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

120

1.25

0.30

1.1

1.2

7.93

8.33

mm/h

0.08

120

(44806420) Estimation of glomerular filtration rate

207

0.82

0.30

2.4

2.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.31

0.30

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

206

0.82

0.29

1.3

1.4

209.86

210.22

pmol/l

0.00

206

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

310

2986

1.04

0.28

2.6

2.2

—

(40761536) Microorganisms panel - Urine sediment

151

1597

0.94

0.28

5.7

3.7

—

(3000764) Benzodiazepines [Presence] in Urine

143

1351

1.06

0.27

1.8

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

385

1.12

0.27

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

376

1.12

0.26

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

282

1.14

0.25

1.3

1.6

369.77

334.57

mu/l

0.39

230

(3012501) Base excess in Blood by calculation

387

1.11

0.25

4.1

4.2

1.99

2.52

mmol/l

1.31

248

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

105

1.24

0.24

1.0

731.38

762.97

ng/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

142

1.20

0.24

1.4

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

388

1.11

0.24

4.1

4.2

4.97

5.05

kpa

0.30

382

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

159

1516

1.05

0.23

2.4

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

322

1.12

0.23

1.4

1.3

—

(3004451) EKG impression Narrative

1.24

0.23

1.8

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

496

1.09

0.22

1.1

2.33

1.76

u/ml

0.17

270

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

116

1.21

0.22

2.1

1.6

—

1089588.90

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

307.64

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

381.31

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.56

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

3.7

—

0.50

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.0

—

8.09

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.7

—

11.80

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.21

0.0

3.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

0.15

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.20

0.0

5.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.23

0.20

1.5

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.23

0.20

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

197

0.86

0.19

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

333

3243

1.03

0.19

2.7

2.3

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

1.18

0.19

1.0

1.2

43.17

28.88

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

132

0.83

0.18

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.21

0.18

5.1

2.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

855

1.05

0.17

2.3

1.8

2.57

5.02

mg/l

2.19

621

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.11

0.17

1.0

1.4

66.86

87.33

nmol/24h

—

(3016879) Cocaine [Presence] in Urine

132

1269

1.04

0.16

1.8

2.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

188

1.12

0.14

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.78

0.14

1.3

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.78

0.14

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.81

0.13

2.0

1.6

0.65

0.49

e9/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

128

0.86

0.13

1.1

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

180

1.11

0.13

1.0

1.1

5.93

10.78

iu/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

267

1.09

0.13

1.6

1.3

6.71

7.24

mmol/l

0.62

237

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

161

1.12

0.13

1.4

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

188

1831

1.03

0.13

2.6

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

127

0.87

0.12

1.6

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

219

0.91

0.11

1.1

—

(21494434) Karyotype in Bone marrow

163

1.11

0.10

1.0

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.11

0.09

1.8

1.1

3.92

17.32

u/ml

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

164

1.10

0.09

17.1

794.44

816.48

nmol/l

0.08

159

(40768793) Breast Pathology biopsy report

442

0.95

0.09

1.3

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

1.11

0.09

1.3

29.33

55.98

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.79

0.08

1.4

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

338

0.95

0.08

1.2

1.1

7.21

2.87

eliau/ml

0.36

159

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

156

1.09

0.08

2.3

1.9

—

(3000060) B lymphocytes [#/volume] in Blood

0.83

0.07

1.2

2.7

—

0.24

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.08

0.07

1.4

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

112

0.89

0.07

1.1

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

112

0.89

0.07

1.1

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

373

1.05

0.07

4.2

3.3

19.24

25.54

mg/l

0.62

253

(3006245) CD3-CD19+ cells/cells in Blood

0.87

0.06

1.6

2.8

19.88

12.97

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

191

0.94

0.04

1.1

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

170

1.06

0.04

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

732

0.98

0.03

1.3

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

148

0.95

0.02

1.6

1.4

118.86

78.13

umol/l

0.56

148

(4094501) Cardiovascular stress test using bicycle ergometer

559

0.98

0.02

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

113

1.06

0.01

1.9

1.6

28.08

34.76

nmol/l

0.44

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

293

1.02

0.01

1.6

—

(40768795) Lymph node Pathology biopsy report

184

1.03

0.00

1.4

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

334

1.02

0.00

1.4

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

101

0.99

0.00

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

186

1.02

0.00

1.5

2.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

238

1.01

0.00

1.6

2.2

31.71

32.50

0.49

238

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

228

2276

1.00

0.00

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

648

1.00

0.00

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.96

0.00

1.6

3.3

8.60

4.88

ug/l

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

266.83

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

3150.00

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

38.48

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

2.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

10.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

3.06

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

1.02

-0.00

1.2

1.3

9.30

9.83

mmol/l

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.93

-0.00

1.0

1.1

85.88

96.68

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.02

-0.00

1.0

1.1

27.72

44.88

iu/ml

—

(40765096) Chromosome analysis panel by Banding

1.00

-0.00

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.4

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

7.08

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_NAIL_INGROW and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_NAIL_INGROW	1.527 [1.36, 1.72]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.303

During the follow-up period (1.1.1998 — 31.12.2019), 809 out of 5436 females with L12_NAIL_INGROW died.

Males

Parameter	HR [95% CI]	p-value
L12_NAIL_INGROW	1.455 [1.26, 1.68]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.054

During the follow-up period (1.1.1998 — 31.12.2019), 676 out of 6439 males with L12_NAIL_INGROW died.

Mortality risk

Mortality risk for people of age

years, who have L12_NAIL_INGROW.

N-year risk	Females	Males
1	0.161%	0.288%
5	0.906%	1.737%
10	2.069%	4.731%
15	4.191%	8.483%
20	7.372%	14.601%

Relationships between endpoints

↥

Index endpoint: L12_NAIL_INGROW – Ingrowing nail

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Ingrowing nail

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints